US20150196498A1 - Hydroxytrosol containing extract obtained from olives and solids containing residues of olive oil extraction - Google Patents
Hydroxytrosol containing extract obtained from olives and solids containing residues of olive oil extraction Download PDFInfo
- Publication number
- US20150196498A1 US20150196498A1 US14/600,174 US201514600174A US2015196498A1 US 20150196498 A1 US20150196498 A1 US 20150196498A1 US 201514600174 A US201514600174 A US 201514600174A US 2015196498 A1 US2015196498 A1 US 2015196498A1
- Authority
- US
- United States
- Prior art keywords
- hydroxytyrosol
- olive
- extract
- oleuropein
- olives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000284 extract Substances 0.000 title claims abstract description 92
- 241000207836 Olea <angiosperm> Species 0.000 title abstract description 35
- 239000007787 solid Substances 0.000 title abstract description 34
- 238000000605 extraction Methods 0.000 title abstract description 30
- 239000004006 olive oil Substances 0.000 title abstract description 28
- 235000008390 olive oil Nutrition 0.000 title abstract description 26
- JUUBCHWRXWPFFH-UHFFFAOYSA-N Hydroxytyrosol Chemical compound OCCC1=CC=C(O)C(O)=C1 JUUBCHWRXWPFFH-UHFFFAOYSA-N 0.000 claims abstract description 483
- 235000003248 hydroxytyrosol Nutrition 0.000 claims abstract description 240
- 229940095066 hydroxytyrosol Drugs 0.000 claims abstract description 240
- YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-hydroxyphenyl)ethanol Chemical compound OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 claims abstract description 84
- DBLDQZASZZMNSL-QMMMGPOBSA-N L-tyrosinol Natural products OC[C@@H](N)CC1=CC=C(O)C=C1 DBLDQZASZZMNSL-QMMMGPOBSA-N 0.000 claims abstract description 42
- 235000004330 tyrosol Nutrition 0.000 claims abstract description 42
- 240000007817 Olea europaea Species 0.000 claims description 73
- 238000000034 method Methods 0.000 claims description 50
- RFWGABANNQMHMZ-HYYSZPHDSA-N Oleuropein Chemical compound O([C@@H]1OC=C([C@H](C1=CC)CC(=O)OCCC=1C=C(O)C(O)=CC=1)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RFWGABANNQMHMZ-HYYSZPHDSA-N 0.000 claims description 45
- 235000011576 oleuropein Nutrition 0.000 claims description 44
- 235000013824 polyphenols Nutrition 0.000 claims description 35
- RFWGABANNQMHMZ-UHFFFAOYSA-N 8-acetoxy-7-acetyl-6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4',5':4,5]benzo[1,2,3-de]quinoline Natural products CC=C1C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O RFWGABANNQMHMZ-UHFFFAOYSA-N 0.000 claims description 34
- HKVGJQVJNQRJPO-UHFFFAOYSA-N Demethyloleuropein Natural products O1C=C(C(O)=O)C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(=CC)C1OC1OC(CO)C(O)C(O)C1O HKVGJQVJNQRJPO-UHFFFAOYSA-N 0.000 claims description 34
- RFWGABANNQMHMZ-CARRXEGNSA-N oleuropein Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)C(=CC)[C@H]1CC(=O)OCCc3ccc(O)c(O)c3 RFWGABANNQMHMZ-CARRXEGNSA-N 0.000 claims description 34
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 32
- 239000000203 mixture Substances 0.000 claims description 28
- DEBZOPZQKONWTK-UHFFFAOYSA-N aldehydic form of oleuropein aglycone Natural products COC(=O)C1=COC(C)C(C=O)C1CC(=O)OCCC1=CC=C(O)C(O)=C1 DEBZOPZQKONWTK-UHFFFAOYSA-N 0.000 claims description 23
- 239000008280 blood Substances 0.000 claims description 10
- 210000004369 blood Anatomy 0.000 claims description 10
- 235000015872 dietary supplement Nutrition 0.000 claims description 10
- 150000002632 lipids Chemical class 0.000 claims description 7
- 230000036542 oxidative stress Effects 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 64
- 239000011347 resin Substances 0.000 abstract description 51
- 229920005989 resin Polymers 0.000 abstract description 51
- 238000004128 high performance liquid chromatography Methods 0.000 abstract description 42
- 238000000746 purification Methods 0.000 abstract description 31
- NOEGNKMFWQHSLB-UHFFFAOYSA-N 5-hydroxymethylfurfural Chemical compound OCC1=CC=C(C=O)O1 NOEGNKMFWQHSLB-UHFFFAOYSA-N 0.000 abstract description 27
- RJGBSYZFOCAGQY-UHFFFAOYSA-N hydroxymethylfurfural Natural products COC1=CC=C(C=O)O1 RJGBSYZFOCAGQY-UHFFFAOYSA-N 0.000 abstract description 25
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 abstract description 10
- 235000000346 sugar Nutrition 0.000 abstract description 10
- 150000008163 sugars Chemical class 0.000 abstract description 8
- 238000005903 acid hydrolysis reaction Methods 0.000 abstract description 7
- 239000000047 product Substances 0.000 description 37
- 230000008569 process Effects 0.000 description 34
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- 238000006460 hydrolysis reaction Methods 0.000 description 32
- 239000000523 sample Substances 0.000 description 31
- 235000013305 food Nutrition 0.000 description 30
- 230000007062 hydrolysis Effects 0.000 description 29
- 239000007788 liquid Substances 0.000 description 28
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 239000006286 aqueous extract Substances 0.000 description 21
- 150000001875 compounds Chemical class 0.000 description 21
- 238000001179 sorption measurement Methods 0.000 description 19
- 238000004519 manufacturing process Methods 0.000 description 18
- 239000003921 oil Substances 0.000 description 18
- 235000019198 oils Nutrition 0.000 description 18
- 239000012071 phase Substances 0.000 description 18
- 238000001223 reverse osmosis Methods 0.000 description 18
- 229920002774 Maltodextrin Polymers 0.000 description 16
- DEBZOPZQKONWTK-KWCYVHTRSA-N oleuropein aglycone Natural products COC(=O)C1=CO[C@H](C)[C@@H](C=O)[C@@H]1CC(=O)OCCc1ccc(O)c(O)c1 DEBZOPZQKONWTK-KWCYVHTRSA-N 0.000 description 16
- 239000003960 organic solvent Substances 0.000 description 16
- 239000008346 aqueous phase Substances 0.000 description 15
- 239000012141 concentrate Substances 0.000 description 15
- 239000012467 final product Substances 0.000 description 14
- 238000004659 sterilization and disinfection Methods 0.000 description 14
- 239000005913 Maltodextrin Substances 0.000 description 13
- 239000006227 byproduct Substances 0.000 description 13
- 229940035034 maltodextrin Drugs 0.000 description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- 239000002253 acid Substances 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 239000007858 starting material Substances 0.000 description 12
- 230000001954 sterilising effect Effects 0.000 description 12
- 150000002989 phenols Chemical class 0.000 description 11
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 11
- 239000003957 anion exchange resin Substances 0.000 description 10
- 235000019658 bitter taste Nutrition 0.000 description 10
- 239000002537 cosmetic Substances 0.000 description 10
- 238000010828 elution Methods 0.000 description 10
- 239000012263 liquid product Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000007791 liquid phase Substances 0.000 description 9
- 230000000717 retained effect Effects 0.000 description 9
- 238000000926 separation method Methods 0.000 description 9
- 235000013399 edible fruits Nutrition 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 7
- 239000010462 extra virgin olive oil Substances 0.000 description 7
- 235000014106 fortified food Nutrition 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 238000001694 spray drying Methods 0.000 description 7
- 239000001117 sulphuric acid Substances 0.000 description 7
- 235000011149 sulphuric acid Nutrition 0.000 description 7
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical class C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 244000061456 Solanum tuberosum Species 0.000 description 6
- 235000002595 Solanum tuberosum Nutrition 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 125000000129 anionic group Chemical group 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 239000000969 carrier Substances 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 230000008020 evaporation Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- BIWKXNFEOZXNLX-BBHIFXBUSA-N oleuropein aglycone Chemical compound COC(=O)C1=CO[C@@H](O)\C(=C\C)[C@@H]1CC(=O)OCCC1=CC=C(O)C(O)=C1 BIWKXNFEOZXNLX-BBHIFXBUSA-N 0.000 description 6
- 108010071584 oxidized low density lipoprotein Proteins 0.000 description 6
- 239000002798 polar solvent Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 230000008030 elimination Effects 0.000 description 5
- 238000003379 elimination reaction Methods 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 238000005342 ion exchange Methods 0.000 description 5
- 239000003456 ion exchange resin Substances 0.000 description 5
- 238000005040 ion trap Methods 0.000 description 5
- 229920003303 ion-exchange polymer Polymers 0.000 description 5
- 239000000575 pesticide Substances 0.000 description 5
- 235000019633 pungent taste Nutrition 0.000 description 5
- 238000011002 quantification Methods 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 125000003118 aryl group Chemical group 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 238000009295 crossflow filtration Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- -1 hydroxytyrosol Chemical class 0.000 description 4
- 150000002500 ions Chemical class 0.000 description 4
- 238000011068 loading method Methods 0.000 description 4
- VPOVFCBNUOUZGG-VVHNFQOZSA-N p-HPEA-EDA Chemical compound C\C=C(\C=O)C(CC=O)CC(=O)OCCC1=CC=C(O)C=C1 VPOVFCBNUOUZGG-VVHNFQOZSA-N 0.000 description 4
- 230000002572 peristaltic effect Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000010463 virgin olive oil Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000003463 adsorbent Substances 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 238000010420 art technique Methods 0.000 description 3
- 102000006995 beta-Glucosidase Human genes 0.000 description 3
- 108010047754 beta-Glucosidase Proteins 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229920001429 chelating resin Polymers 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 239000008121 dextrose Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000008157 edible vegetable oil Substances 0.000 description 3
- 235000021010 extra-virgin olive oil Nutrition 0.000 description 3
- 235000019253 formic acid Nutrition 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000012466 permeate Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Chemical compound C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 2
- GYFAGKUZYNFMBN-UHFFFAOYSA-N Benzo[ghi]perylene Chemical group C1=CC(C2=C34)=CC=C3C=CC=C4C3=CC=CC4=CC=C1C2=C43 GYFAGKUZYNFMBN-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000005909 Kieselgur Substances 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 2
- XLPXUPOZUYGVPD-XNJYKOPJSA-N Oleacein Chemical compound C\C=C(/C=O)C(CC=O)CC(=O)OCCC1=CC=C(O)C(O)=C1 XLPXUPOZUYGVPD-XNJYKOPJSA-N 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 238000010162 Tukey test Methods 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 235000020224 almond Nutrition 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 125000005605 benzo group Chemical group 0.000 description 2
- 238000013375 chromatographic separation Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- XLPXUPOZUYGVPD-UHFFFAOYSA-N dialdehydic form of decarboxymethyl oleuropein aglycone Natural products CC=C(C=O)C(CC=O)CC(=O)OCCC1=CC=C(O)C(O)=C1 XLPXUPOZUYGVPD-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000004880 explosion Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- RDYMFSUJUZBWLH-AZVNHNRSSA-N qy5y9r7g0e Chemical compound C([C@H]12)OS(=O)OC[C@@H]1[C@]1(Cl)C(Cl)=C(Cl)[C@@]2(Cl)C1(Cl)Cl RDYMFSUJUZBWLH-AZVNHNRSSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical group CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- QFRYQWYZSQDFOS-UHFFFAOYSA-N verbascoside Natural products CC1OC(COC2C(O)C(COC3OC(C(O)C(O)C3O)C(=O)O)OC(Oc4cc(O)cc5OC(=CC(=O)c45)c6ccc(O)c(O)c6)C2O)C(O)C(O)C1O QFRYQWYZSQDFOS-UHFFFAOYSA-N 0.000 description 2
- GMQXOLRKJQWPNB-UHFFFAOYSA-N (8E)-ligstroside Natural products CC=C1C(CC(=O)OCCC=2C=CC(O)=CC=2)C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O GMQXOLRKJQWPNB-UHFFFAOYSA-N 0.000 description 1
- LGERRYPEGFPVAJ-UHFFFAOYSA-N 1,12-phenyleneperylene Natural products C1=C2C3=CC=CC=C3C3=CC=C(C=CC=C45)C4=C3C2=C2C5=CC=CC2=C1 LGERRYPEGFPVAJ-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- XMTQQYYKAHVGBJ-UHFFFAOYSA-N 3-(3,4-DICHLOROPHENYL)-1,1-DIMETHYLUREA Chemical compound CN(C)C(=O)NC1=CC=C(Cl)C(Cl)=C1 XMTQQYYKAHVGBJ-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 101100313763 Arabidopsis thaliana TIM22-2 gene Proteins 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- 206010013496 Disturbance in attention Diseases 0.000 description 1
- 239000005510 Diuron Substances 0.000 description 1
- FIKLMMHLPVXWJN-WRWORJQWSA-N Elenolic acid Chemical compound COC(=O)C1=CO[C@@H](O)C(=CC)[C@@H]1CC(O)=O FIKLMMHLPVXWJN-WRWORJQWSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical group CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- 235000002725 Olea europaea Nutrition 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 239000005621 Terbuthylazine Substances 0.000 description 1
- 206010043521 Throat irritation Diseases 0.000 description 1
- 235000021068 Western diet Nutrition 0.000 description 1
- FXOYRRMUPLYUEW-BTJRQGLLSA-N [H][C@@]1(CC(=O)OCCC2=CC(O)=C(O)C=C2)C(C(=O)OC)=COC(C)C1C=O.[H][C@@]1(CC(=O)OCCC2=CC(O)=C(O)C=C2)C(C(=O)OC)=COC(O)/C1=C\C Chemical compound [H][C@@]1(CC(=O)OCCC2=CC(O)=C(O)C=C2)C(C(=O)OC)=COC(C)C1C=O.[H][C@@]1(CC(=O)OCCC2=CC(O)=C(O)C=C2)C(C(=O)OC)=COC(O)/C1=C\C FXOYRRMUPLYUEW-BTJRQGLLSA-N 0.000 description 1
- RFWGABANNQMHMZ-ZCHJGGQASA-N [H][C@@]1(CC(=O)OCCC2=CC(O)=C(O)C=C2)C(C(=O)OC)=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)/C1=C/C Chemical compound [H][C@@]1(CC(=O)OCCC2=CC(O)=C(O)C=C2)C(C(=O)OC)=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)/C1=C/C RFWGABANNQMHMZ-ZCHJGGQASA-N 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000005349 anion exchange Methods 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 208000037849 arterial hypertension Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000011365 complex material Substances 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 229960002887 deanol Drugs 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 1
- 239000012972 dimethylethanolamine Chemical group 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- UYMKPFRHYYNDTL-UHFFFAOYSA-N ethenamine Chemical compound NC=C UYMKPFRHYYNDTL-UHFFFAOYSA-N 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 239000002803 fossil fuel Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229930182480 glucuronide Natural products 0.000 description 1
- 150000008134 glucuronides Chemical class 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- GMQXOLRKJQWPNB-MVVLSVRYSA-N ligstroside Chemical compound O([C@@H]\1OC=C([C@H](C/1=C\C)CC(=O)OCCC=1C=CC(O)=CC=1)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GMQXOLRKJQWPNB-MVVLSVRYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 238000001728 nano-filtration Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229940114496 olive leaf extract Drugs 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 210000003254 palate Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000000447 pesticide residue Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 231100000683 possible toxicity Toxicity 0.000 description 1
- 231100000175 potential carcinogenicity Toxicity 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000003128 rodenticide Substances 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- ODCWYMIRDDJXKW-UHFFFAOYSA-N simazine Chemical compound CCNC1=NC(Cl)=NC(NCC)=N1 ODCWYMIRDDJXKW-UHFFFAOYSA-N 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000011269 tar Substances 0.000 description 1
- 231100000378 teratogenic Toxicity 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- FZXISNSWEXTPMF-UHFFFAOYSA-N terbutylazine Chemical compound CCNC1=NC(Cl)=NC(NC(C)(C)C)=N1 FZXISNSWEXTPMF-UHFFFAOYSA-N 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 210000003901 trigeminal nerve Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- KDSWDGKIENPKLB-QJDQKFITSA-N verbascoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC(=O)CCC=2C=C(O)C(O)=CC=2)[C@@H](CO)O[C@@H](OCCC=2C=C(O)C(O)=CC=2)[C@@H]1O KDSWDGKIENPKLB-QJDQKFITSA-N 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
Definitions
- the present invention relates to a hydroxytyrosol containing extract obtained from olives and/or the solid-containing residues of olives after the extraction of olive oil. More particularly, the invention relates to the production of hydroxytyrosol-containing extracts to be used as a source of hydroxytyrosol in food, medical and cosmetic industries.
- Hydroxytyrosol is present in olives and olive oil and has the following formula:
- the residues of olive oil extraction of interest for the present application exclude the olive tree leaves, because the leaves are removed before oil extraction. Moreover, hydroxytyrosol extraction from leaves faces different starting compositions (and therefore different extraction problems) than extraction from olives or olive residues.
- the residues of olives as obtained from olive oil extraction processes of interest for the present application can be classified as:
- the green olives extracts of the invention are preferred to the extracts of residues of olive oil production in view of their greater amount of hydroxytyrosol and of the reduced content of hydroxymethylfurfural.
- pomaces or “solid residue” is designating both “orujo”, “defatted orujo” “orujillo” and “alperujo”.
- Preferred starting materials for the present invention are olives, more preferably green olives, and pomaces.
- Oleuropein the phenolic compound that makes the fruit of the olive bitter, is water-soluble rather than fat-soluble, and it gets poorly transferred into the oil when the fruit is pressed, thus average content of oleuropein in extra virgin and virgin olive oils is from 1 ppb to 11 ppm.
- Oleuropein is present in olives and olive oil and has the following formula:
- oleuropein related compounds are more oil soluble than oleuropein itself, and do end up at a higher content in the oil, in the form of isomer (or isomers) of oleuropein aglycone (e.g.: aldehydicic form of oleuropein aglycone, AOA), and dialdehydic form of elenolic acid linked to hydroxytyrosol or tyrosol, respectively named 3,4-DHPEA-EDA and p-HPEA-EDA, that are the olive polyphenols mainly responsible for the bitter taste according to Gutierrez-Rosales and co-authors, J. Agric. Food Chem. 2003, 51, 6021-6025.
- isomer (or isomers) of oleuropein aglycone e.g.: aldehydicic form of oleuropein aglycone, AOA
- Oleuropein aglycone e.g: aldehydic form of oleuropein aglycone
- Oleuropein aglycone is present in olive oil and in crushed olives during oil extraction process and has the following formula:
- U.S. Pat. No. 6,361,803 which is incorporated by reference, discloses extraction of hydroxytyrosol (and other compounds) by neutral or acid hydrolysis of olive pulp residues at reflux for one hour (ex.12).
- the extracted water solution is loaded on an absorption XAD-7 column that is eluted with methanol to recover the extracted hydroxytyrosol.
- U.S. Pat. No. 6,361,803 requires the use of organic polar solvents, to recover hydroxytyrosol with a minimum purity grade, in addition (ex.12) freeze precipitation of some impurities from the methanol solution is necessary.
- Polar aqueous solvents are selected among methanol, ethanol, acetonitrile or acetone, while polar organic solvents are selected, for example, among esters, amides, dimethyl sulfoxide, dioxane, DMF and their mixtures. Most of these solvents are toxic and very difficult to completely eliminate from the desired hydroxytyrosol product. Accordingly, traces of the utilized solvents will be found in the final product even after several purification steps, thus rendering the hydroxytyrosol obtained according to this process not suitable for a safe application in the alimentary, cosmetic and pharmaceutical field.
- the final product is not suitable for use in fortifying foods, particularly edible oils, without use of ethanol and acetic acid as additives to the extract to obtain a stable food product: the resulting food product (oil plus hydroxytyrosol containing extract, ethanol and acetic acid) is not acceptable in the food industry.
- WO 2004/005228 discloses hydrolysis at room temperature of vegetation water obtained from olive oil extraction by incubation of the acidified vegetation water for at least two months and preferably 6-12 months until at least 50% (preferably 90%) of the oleuropein originally present in the vegetation water has been converted to hydroxytyrosol.
- the incubated vegetation water is extracted with an organic solvent, for example ethyl acetate, or it is contacted with a supercritical fluid (CO 2 ), to produce a fraction rich in hydroxytyrosol.
- CO 2 supercritical fluid
- EP 1623960 which is incorporated by reference, 0, discloses a process of recovery of hydroxytyrosol, and tyrosol, from alpechin by means of filtration in a complicated plant consisting of three units (Ex. 1) and subsequent separation. The tyrosol is then oxidated to hydroxytyrosol in a protic solvent (alcohol or water) to obtain a final product that is semi-synthetic. Additionally, EP 1623960 discloses that concentration by nanofiltration and reverse osmosis of vegetation waters (alpechin) are carried out at neutral or alkaline pH (claim 4 ). This process has two important problems.
- a first drawback is that hydroxytyrosol degradation increases at neutral and alkaline conditions giving unwanted products that are difficult to remove, and, in addition, due to the fact that no acid hydrolysis is carried out the oleuropein content should be still high.
- the obtainable concentration factor is poor, thus the maximum concentration allowed for hydroxytyrosol according Ex-1 (see table 1) is in the range from 1.2 to 1.6 g/L.
- the above mentioned techniques are either too long or too complex, or too harsh, or all of the above; this results in that the amount of remaining oleuropein, i.e. the amount that is not hydrolyzed, and/or the amount of the hydrolysis by-products such as hydroxymethylfurfural is high enough to make difficult the subsequent purification steps.
- Extracts should not transfer to oils any bitter polyphenolic substances, however, the health beneficial compounds, namely hydroxytyrosol, are always associated to bitter polyphenols in the known extracts.
- bitter and pungent polyphenols present in olive oil are also presents in olives and are also responsible for their bitterness and pungency, those being the ones that best correlate with the bitterness attribute the oleuropein and the aldehydic form of oleuropein aglycone.
- the crushing of olives to prepare olive oil or olive extracts produces the hydrolysis of oleuropein by endogenous ⁇ -glucosidase rendering oleuropein aglycone as transient specie that forms the aldehydic form of oleuropein aglycone.
- any way set up in order to increase antioxidant capacity using techniques based on fortification of foods with olive polyphenols should not alter food natural organoleptic characteristics, nor increase the amount of the bitter tasting olive polyphenols, otherwise incurring with the subsequent alteration of organoleptic properties of the food, thus causing non-pleasant taste due to excessive bitterness, pungency and/or astringency, and subsequently causing rejection of the fortified food from many consumers.
- U.S. Pat. No. 6,942,890 which is incorporated by reference, discloses a method of fortifying food products adding to such products solid matter derived from olive fruits, resulting in an increase of the level of antioxidants, particularly of olive polyphenols.
- NDA EFSA Panel on Dietetic Products, Nutrition and Allergies
- the starting materials especially olives and pomaces, contain inter alia a high amount of phenolic compounds in the form of glucoside and/or its esters including oleuropein, ligustroside, verbascoside and several flavonoids.
- oleuropein ligustroside
- verbascoside verbascoside
- flavonoids Several other natural compounds are present. It is very easy to degrade the starting compounds into a plethora of by-products.
- organic solvents As by-products must be eliminated to purify hydroxytyrosol, in the known art the use of organic solvents is required in order to purify the hydroxytyrosol during the subsequent purification steps on chromatographic columns.
- organic solvents for example methanol, when eluting from a resin column, is inconvenient, particularly when the final product obtained is to be used in the alimentary, cosmetic and pharmaceutical field.
- the known hydroxytyrosol-rich extracts are not suitable to be used as additives for foods, especially edible oils.
- hydroxytyrosol containing extract that is rich in hydroxytyrosol and has low content of starting products and of bitter products such as oleuropein and verbascosides, and of by-products, particularly hydroxymethylfurfural and in general has a very low content in sugars and in salts.
- Such aim is achieved by means of the present invention that provides an extract, as obtainable by extraction from a starting material selected from olives and/or pomaces, residues of olives after the extraction of olive oil, characterized in that said extract contains hydroxytyrosol and tyrosol, the amount of sugars per 100 g or 100 mL of extract is 0.5 g or less, the residual content of Benzo[a]pyrene in said extract is less than 2 microg/Kg (weight BaP/weight of extract as dry matter), containing a weight ratio of hydroxytyrosol to hydroxymethylfurfural of between 45:1 and 10000:1 and in that the content of hydroxytyrosol in said extract is at least 0.5% (w/w) and the hydroxytyrosol purity is at least 40% (by HPLC 280 nm).
- a preferred olive extract is that one obtained according to the process hereinafter disclosed, having a content in hydroxytyrosol of at least 0.5% by weight (w/w), and a purity of hydroxytyrosol of at least 40% (by HPLC at 280 nm).
- This extract is free of organic solvents (the residual content of organic solvents is less that 1 ppb and preferably 0 ppm) and substantially free of sugars, and the content in hydroxytyrosol of that extract is at least 0.5% (w/w) and the purity of hydroxytyrosol is at least 40% (by HPLC at 280 nm).
- a hydroxytyrosol content of at least 10% (w/w) is preferred, and more preferably at least 35% (w/w); the purity of hydroxytyrosol at 80% is preferred, and more preferably at 90% (by HPLC at 280 nm).
- some of the polyphenols present in olives are responsible for their bitterness, the ones that best correlate with this attribute being the oleuropein and the aldehydic form of oleuropein aglycone.
- the use of olive extracts containing oleuropein and/or the aldehydic form of oleuropein aglycone can modify the taste of foods in which the aforementioned extract is incorporated, resulting in a lower acceptance by consumers.
- Olive extract rich in hydroxytyrosol obtained according to the invention process (as per co-pending U.S. application Ser. No. 12/524,603) is virtually free of oleuropein and of the aldehydic form of oleuropein aglycone, the total amount of each compound being less than 500 ppm (their detection limit), because no organic solvent is used, where these molecules, much more hydrophobic than hydroxytyrosol, are more soluble, for obtaining the extract, together with the combination of purifying steps used, chromatographic columns, for obtaining the extract.
- the olive extract rich in hydroxytyrosol obtained according to the invention process has a very low content of hydroxymethylfurfural, being the ratio hydroxytyrosol/hydoxymethylfurfural (w/w) higher than 45:1 before column purification or higher than 9000:1 after purification steps, because the controlled extraction conditions pH time and temperature, together with the combination of purifying steps used, chromatographic columns, for obtaining the extract.
- An additional advantage of the above mentioned olive extracts is the purification from the residues of pesticides present in raw materials, i.e. in the olives and olive pomaces.
- potentially toxic chemicals such as insecticides, herbicides, fungicides, rodenticides, etc. . . . , such as: diuron, terbuthylazine, simazine, ⁇ -endosulfan, and ⁇ -endosulfan may be present in the starting material.
- HMF Hydroxymethylfurfural
- 5-(Hydroxymethyl)furfural is an organic compound derived from dehydration of certain sugar, especially in acidic conditions. This yellow low-melting solid is highly water-soluble.
- the molecule consists of a furan ring, containing both aldehyde and alcohol and functional groups. HMF has been identified in a wide variety of heat-processed foods including milk, fruit juices, spirits, honey, etc. . . .
- HMF is a natural component in heated food but is usually present in low concentrations.
- the daily intake of HMF may underlie high variations due to individual consumption-patterns. It has been estimated that in a western diet, about 5-10 mg of HMF are ingested per day from food.
- HMF was used in food for flavoring purposes, but in Europe this practice now is suspended. HMF is also found in cigarette smoke.
- PAHs Polycyclic aromatic hydrocarbons
- PAHs are potent atmospheric pollutants that consist of fused aromatic rings and do not contain heteroatoms or carry substituents. PAHs occur in oil, coal and tar deposits, and are produced as byproducts of fuel burning (whether fossil fuel or biomass). As a pollutant, they are of concern because some compounds have been identified as carcinogenic, mutagenic and teratogenic. PAHs are also found in cooked foods. Studies have shown that high levels of PAHs are found, for example, in meat cooked at high temperatures such as grilling or barbecuing, and in smoked fish. As olive oil extraction residues are complex materials it is possible that harsh conditions in temperature (i.e. steam explosion extraction) during olive polyphenol extraction could produce such PAHs at residual levels, being then desirable that a process to extract olive polyphenols avoid such PAHs residual levels formation.
- harsh conditions in temperature i.e. steam explosion extraction
- Benzo[a]pyrene (BaP) is commonly used as an indicator species for PAHs contamination and most of the available data refer to this compound.
- AIIs, HMF, PAHs and above mentioned pesticides have molecular structures (e.g. the core of triazines in most of the pesticides) capable of interacting with the absorption resins and then are eluted from the resin together with other components of the extract when using organic solvents.
- the process of preparing the extract of the invention entails the acidic hydrolysis in water of the starting materials at a temperature not exceeding 140° C., preferably within the range from 70° C. to 130° C. and most preferably above the reflux temperature, in the range of 110° C. to 130° C. and in a pressurized condition, e.g. in an continuous sterilization system, at a pressure within the range of atmospheric pressure to 10-20 psi above the atmospheric pressure.
- the pH of the acidified mixture that undergoes the hydrolysis is within the range of 1.0 to 6.0.
- the mixture after the hydrolysis is clarified by physical methods known in the art, e.g. by filtering and/or centrifuging, to remove the suspended solids from the hydrolysis water solution, and to obtain a clarified solution substantially free of solids in suspension.
- the starting materials are olives or pomaces, i.e. the above defined residues from olive oil extraction.
- Preferred olives are green olives, pomaces are preferably free from oil. Oil is removed either before or after the hydrolysis step by means known in the art (e.g. those used to prepare defatted orujo or orujillo) or by use of diatomaceous earth or other filter means.
- the above steps are followed by the steps of loading the product thus obtained in at least one chromatographic column of an acid activated anion exchange resin, and of eluting the products retained in said chromatographic column with water.
- the invention provides for a further purification step carried out by loading the water-eluted solution from the first column (anion exchange) in at least one chromatographic column of adsorbent non-ionic resins and of eluting the products retained in said second chromatographic column with water.
- the liquid product is concentrated e.g. by reverse osmosis concentration.
- the resulting liquid product is brought to a solid form, e.g. by freeze-drying, vacuum rotaevaporation or spray drying, with or without carriers such as maltodextrines.
- the extract of the invention has a ratio by weight of hydroxytyrosol:oleuropein that is greater than 200:1, preferably also a ratio (by weight, i.e. w/w) of hydroxytyrosol: aldehydic form of oleuropein aglycone that is between 5:1 and 850:1.
- the extract according to the invention is free from oleuropein and aldehydic form of oleuropein aglycone (by HPLC 280 nm).
- the invention extract has a ratio hydroxytyrosol:tyrosol that is greater than 55:1 by weight, preferably within the range of 55:1 to 618:1.
- the extract is free from organic polar solvents.
- a further object of the invention is the use of an extract as above disclosed as a source of hydroxytyrosol in the food industry as additive or as functional ingredient; as a source of hydroxytyrosol in the cosmetic industry or as a source of hydroxytyrosol in the pharmaceutical industry.
- an extract according to the invention is added to said product.
- the invention provides several advantages over the prior art techniques.
- the hydrolysis step is carried out, according to the present invention, using just water and mineral acid, keeping the temperature in the claimed range preferably above the reflux temperature, using a combination of heating and pressure.
- pressure is applied together with the claimed heating temperature, the resulting hydrolysis reaction is almost completed in about half an hour, without significant formation of by-products and with a very good conversion of the starting material (oleuropein) into the final desired product (hydroxytyrosol).
- the hydrolysis step according to the present invention allows to obtain, in a short time, a very good yield in hydroxytyrosol together with a quite complete absence of those by-products, that are difficult to eliminate and which are instead formed, according to the prior art, in significant amounts.
- the hydrolysis step provides for another advantage.
- the hydrolysis step provides a sterilization of the water solution, i.e. of the products involved, that is very useful, as the starting material (for example pomaces) used in the processes for the preparation of hydroxytyrosol, usually comes from already treated materials, and generally requires some depuration-sterilization pre-treatments, to give a safe hydroxytyrosol final product.
- the hydrolysis step contemporaneously allows to carry out the hydrolysis reaction and provides for the necessary sterilization of the products involved, thus avoiding the necessity to carry out any sterilization step on the starting material as well as providing for a hydrolysed material that is ready for further uses, without any additional sterilization treatment.
- the hydrolysis step is followed by at least a purification step, which is carried out by loading the product obtained from the hydrolysis step in at least a single chromatography column system or in a two chromatography columns system and eluting the hydroxytyrosol retained in said chromatographic columns with water.
- a purification step which is carried out by loading the product obtained from the hydrolysis step in at least a single chromatography column system or in a two chromatography columns system and eluting the hydroxytyrosol retained in said chromatographic columns with water.
- concentration step that allows to enrich the hydroxytyrosol content after the purification steps.
- These purification steps produce a liquid extract, substantially free from sugars and salts, resulting in a very important reduction of the osmotic pressure during the concentration step of the purified liquid extract permitting thus a very high concentration factor (until 350 times).
- This concentration step provides a “concentrate” characterized by a high content of hydroxytyrosol, which can be directly used for further treatments.
- an additional advantage of the invention's olive extracts is the purification from the residues of pesticides present in raw materials, i.e. in the olives and pomaces.
- FIG. 1 is a schematic view of an apparatus according to an exemplary embodiment of the invention.
- FIGS. 2-4 are chromatograms of three hydroxytyrosol containing products according to three embodiments of the invention process.
- FIG. 5 is a chromatographic profile showing the separation of hydroxytyrosol and tyrosol peaks in adsorption column eluted with water. Also 2 marks are signaling the bed volumes at which sample spot 2 a and sample spot 2 b were taken.
- FIG. 6 a is a HPLC chromatogram of the sample spot 2 a (punctual sample at 2 BV) taken during collection of eluate fraction showing a complete separation of hydroxytyrosol and tyrosol in adsorption column eluted with water.
- FIG. 6 b is a HPLC chromatogram of the sample spot 2 b taken (punctual sample at 11.8 BV), showing impurification of hydroxytyrosol with tyrosol that is eluted later than hydroxytyrosol in adsorption column eluted with water.
- FIG. 7 is a chromatogram of hydrolysis reaction of oleuropein.
- FIG. 8 a is a graphical representation of ratio hydroxytyrosol/tyrosol (w/w) in 17 different production lots of olive extracts production from orujillo.
- FIG. 8 b is a graphical representation of the ratio hydroxytyrosol/hydroxymethylfurfural (w/w), at the crude aqueous extract after centrifugation in 17 different production lots of olive extracts production from orujillo.
- FIG. 9 shows the ion species detected in purified olive extract in liquid form having a hydroxytyrosol concentration of 41.5% (w/w) with an HPLC purity of 94.8% and a ratio hydroxytyrosol/tyrosol (w/w) of 110/1 obtained according to Example 15 on the HPLC-DAD-MS systems.
- FIG. 10 is a Chromatogram DAD (280 nm); BPC (Base Peak Chromatogram) in negative ( ⁇ ) and positive (+) ionization mode, for purified olive extract in liquid form having a hydroxytyrosol concentration of 41.5% (w/w) with an HPLC purity of 94.8% and a ratio hydroxytyrosol/tyrosol (w/w) of 110/1 obtained according to Example 15 dissolved in MeOH 0.1% HCOOH 100 mg/ml.
- BPC Base Peak Chromatogram
- FIG. 11 is a graphical representation of a number of capsules vs. net weight of olive extract inside the dietary supplement.
- FIG. 12 is a graphical representation of the plasmatic level of oxidized LDL in the participants of the groups 1 and 2 of the intervention study. The difference at the level of oxidized LDL was determined as statistically significantive when compared Group 2 with the control Group 1, p ⁇ 0.01 (Tukey's Test).
- the invention apparatus comprises a means, or reactor, 1 , preferably a continuous sterilization system, in which the hydrolysis according to the invention process is carried out.
- the hydrolysis is carried out at a temperature that does not exceed 140° C., in a reactor.
- the temperature range is 70 to 130° C. and most preferably it is above reflux temperature, in a range 110 to 130° C., at a pressure of 10 to 20 psi above the atmospheric pressure and for a time length within the range of 15 to 45 minutes.
- the hydrolysis temperature is within the range of 118 to 126° C. and in the most preferred embodiment the hydrolysis is carried out at 120-121° C., at 15 psi (over the atmospheric pressure) for 30 minutes.
- a preferred reactor is a continuous sterilization system.
- the continuous sterilization system 1 is provided with feeding means 2 for feeding to it the starting materials, namely the residues, or by-products, of olive oil extraction, namely pomaces (i.e. the solid residues of the pressed olives).
- the starting materials namely the residues, or by-products, of olive oil extraction, namely pomaces (i.e. the solid residues of the pressed olives).
- Continuous sterilization system 1 is suitable to treat the starting materials in a continuous process rather than batchwise.
- Heating means 3 for heating the reactor 1 to the above mentioned temperatures are provided in a known way, e.g. as a jacket around the reactor.
- Reactor 1 is also provided with a supply of demineralized water 4 and with means 6 to stir the water mixture of starting product.
- the ratio water to solids is within the range of 1:1 to 4:1.
- the hydrolysis process is carried out at a pH of 1.0 to 6.0, preferably of 1.0 to 3.0.
- the required amount of acid, preferably sulphuric acid, is obtained from acid tank 5 .
- the combination of acidic conditions and of temperature in the claimed ranges results in a hydrolysis process that is fast and efficient and can last for 30 minutes only, at 120-123° C. and a pressure of 15 psi above the atmospheric pressure. Moreover, the process also results in the sterilization of the hydrolysis products.
- the outlet of continuous sterilization system, i.e. reactor, 1 is connected with a filter 7 for removing solids from the reaction mixture containing hydroxytyrosol and other phenols.
- the filtered portion is then sent to a further separation means, preferably a centrifuge 8 , where further solids are removed from the reaction mixture to obtain a liquid substantially free from suspended solids, i.e. a solution that is suitable for the following purification.
- the clarified liquid after centrifugation has a brownish color and is preferably stored in reservoir 9 .
- the clarified liquid A is now containing hydroxytyrosol, a residue of oleuropein and minor amounts of phenols and other products.
- FIG. 2 chromatogram shows the composition and the percent of the detected compounds in this liquid and is obtained by HPLC at 280 nm; the major peak at 9.317 minutes is hydroxytyrosol and the peak at 13.150 minutes is tyrosol.
- liquid A is concentrated by evaporation or tangential flow filtration (TFF), (e.g. by using a reverse osmosis system).
- concentration step can be carried out on liquid A directly or, preferably, after a purification step by means of at least one chromatographic column.
- storage tank, or reservoir, 9 is connected with means of concentrating 10 , e.g. by TFF or preferably by reverse osmosis, and to purification means.
- Purification means comprises in one embodiment a single column system comprising a chromatographic column of a resin selected from acid activated anion exchange resins.
- purification means comprises, in addition to the above mentioned first column of acid activated anion exchange resins at least a further, second, chromatographic column of a resin selected from adsorbent non-ionic resins.
- the acid activated anion exchange resin is a weakly basic anion exchange resin
- the adsorbent non-ionic resin is a macroreticular cross-linked aromatic polymer
- the anion exchange resins used as a chromatographic resin for the purification of hydroxytyrosol of the present invention are not particularly limited so long as they can be acid activated.
- preferred weakly basic anion exchange resins include polyamine-type resins (including polyamine-type chelating resins) such as reaction products of a styrene/divinylbenzene copolymer and diethylenetriamine or other, and resins as polymerization products of compounds mainly comprising allylamine, vinylamine or other; and acrylic resins such as copolymers of divinylbenzene and amide compounds which comprise acrylic acid or methacrylic acid and dimethylaminopropylamine or other.
- resins may also be used in which the aforementioned weakly basic anion exchange resin is partly substituted with strongly basic exchange groups such as trimethylamine, dimethylethanolamine or other. More specifically, known in the art resins which have been used so far can be used, for example, Diaion WA10, WA20, WA21 and WA30 (Mitsubishi Chemical), Amberlite IRA-35, IRA-67 (IRA-68), IRA-93ZU, IRA-94S, IRA-478 (Rhöm & Haas), WGR-2 (Dow Chemical) and other.
- these resins are acid activated before being used, preferably with acetic acid. These resins are particularly suitable for the invention process in view of their low cost and of the fact that they can be regenerated in mild conditions. Additionally, the weakly basic nature of the resin allows the partial separation of hydroxytyrosol and tyrosol molecules. From the comparison of the peak ratio hydroxytyrosol/tyrosol and the HPLC purity of the hydroxytyrosol peak of FIGS. 2 and 3 , it can be appreciated the efficiency of the chromatographic separation according to the invention.
- Suitable adsorption resins are based on non-ionic, hydrophobic, macroreticular cross-linked aromatic polymer. Such resins are typically aromatic polymers, such as styrene and divinylbenzene copolymers, which may be cross-linked. Such resins are known and are generally prepared by polymerization of the appropriate monomers.
- the adsorption resins used as a chromatographic resin for the purification of hydroxytyrosol of the present invention are not particularly limited so long as they can be water eluted.
- Examples of preferred adsorption resins include: Amberlite® XAD-4, XAD-7, XAD-1180, XAD-16 and XAD-1600 (available from Rohm & Haas); XUS-40323.00, XUS-40285.00 and XUS-40283.00 (available from Dow Chemical Co.); and SP-700, SP-825, SP850, Diaion HP 10, HP 20, HP 30, HP 40 and HP 50 (available from Mitsubishi Chemical).
- the process of the invention provides for a two-step purification on chromatographic columns.
- Liquid A as obtained from the initial steps a) and b), i.e. hydrolysis and solid separation, is charged into column 11 , containing the anion exchange resin 12 as above detailed.
- the permeate is sent to waste treatment (not shown).
- Demineralized water from water supply 13 is then fed to column 11 to elute the retained products and the eluted liquid is collected in reservoir 14 .
- the thus obtained liquid product (liquid B) has a purity in hydroxytyrosol of at least 75%, and generally of at least 80%, the purity being determined as the % of the peak areas in a chromatogram by HPLC at 280 nm.
- the recovery of retained hydroxytyrosol from the resin is at least 85% and is generally at least 90%.
- FIG. 3 shows the relevant HPLC chromatogram of the obtained purified liquid product B.
- liquid product B is charged into column 15 , containing a non-ionic adsorption resin 16 , as above detailed.
- the permeate is sent to waste treatment and the adsorbed hydroxytyrosol is recovered by elution with demineralized water from supply 13 and is collected in reservoir 17 .
- Liquid C i.e. the liquid collected in reservoir 17 has a purity in hydroxytyrosol of at least 90%, and generally of at least 95%, the purity being determined as the percent of the peak areas in a chromatogram by HPLC at 280 nm.
- the recovery of retained hydroxytyrosol from the resin is at least 90% and is generally at least 95% and substantially quantitative.
- FIG. 4 shows the relevant HPLC chromatogram of the obtained purified liquid product C.
- FIG. 1 also shows a source of acetic acid 18 that is connected to column 11 for acid activation of resin 12 and a source of NaOH 19 or other suitable base for regeneration of the same. Additionally, a source of NaOH 19 for regeneration of resin 16 is connected to column 15 and a source of sulphuric acid 21 for resin surface activation is also shown.
- liquid B and liquid C can be concentrated in concentration means 10 , e.g. by evaporation or TFF, preferably by reverse osmosis; concentration is preferably carried out on liquids B and C, preferably liquid C, to a hydroxytyrosol content that is easily up to 10%, and that can reach 20%, 35% and even 40% by weight of hydroxytyrosol in the concentrated liquid product (i.e. extract).
- concentration means 10 e.g. by evaporation or TFF, preferably by reverse osmosis
- concentration is preferably carried out on liquids B and C, preferably liquid C, to a hydroxytyrosol content that is easily up to 10%, and that can reach 20%, 35% and even 40% by weight of hydroxytyrosol in the concentrated liquid product (i.e. extract).
- the liquid products obtained by the previously discussed steps are dried in dryer means 20 , e.g. freeze-dryer, vacuum rotoevaporator or preferably by spray-dryer, to produce a solid final product.
- dryer means 20 e.g. freeze-dryer, vacuum rotoevaporator or preferably by spray-dryer.
- the final product characteristics will be different according to the starting product (A, B or C) that is dried, the purity of the dry product being within the range of 45% to 99% (HPLC at 280 nm).
- This drying step is preferably carried out on liquid products B and C, after concentrating them as above disclosed.
- the drying step can advantageously make use of carriers suitable for the final use of the dry product; suitable carriers are e.g. maltodextrines, lactose, lecithins, caseinates etcetera.
- Suitable drying techniques are known in the art and comprise spray drying (usually with the use of carriers), freeze-drying and water evaporation under vacuum.
- the resulting products will have a hydroxytyrosol content of 0.5% to 10% and up to 20% (w/w) if a carrier is used, the hydroxytyrosol content can reach up to about 95% (w/w) if no carrier is used.
- the invention process provides a purified liquid product (B and especially C) that is so pure that it can be evaporated to a dry powder even without carriers, this being not possible with known techniques.
- the extracts of the invention are suitable to prepare oral composition
- the oral composition of the invention is comprising olive polyphenols in an amount effective to provide in a daily serving at least 5 mg of hydroxytyrosol and its derivatives (e.g. oleuropein complex and tyrosol) wherein said olive polyphenols comprises a weight ratio of hydroxytyrosol to oleuropein greater than 200:1.
- hydroxytyrosol and its derivatives e.g. oleuropein complex and tyrosol
- a ion exchange resin of the anionic type for example, Diaion WA10 may be used.
- the liquid phase recovered at the end of the column does not contain any hydroxytyrosol, which is instead continuously eluted with demineralized water until at least 90% of the initially charged hydroxytyrosol is recovered.
- the eluted phase contains approximately 1.27 g of hydroxytyrosol with an HPLC purity of about 80.85%.
- an ion exchange resin of the anionic type for example, IRA-67 may be used.
- the liquid phase recovered at the end of the column, does not contain any hydroxytyrosol, which is instead continuously eluted with demineralized water until at least 90% of the initially charged hydroxytyrosol is recovered.
- the eluted phase coming from the first column is charged on a column containing an adsorption resin.
- resin XAD-1180 may be used.
- the liquid phase recovered at the end of the column does not contain any hydroxytyrosol.
- hydroxytyrosol is eluted from the resin with demineralized water until at least 90% of the initially charged hydroxytyrosol is recovered.
- the eluted phase contains approximately 1.14 g of hydroxytyrosol with an HPLC purity of about 95.72%.
- the aqueous phase obtained in Example 1 before the centrifugation step is concentrated by evaporation in order to reach a final volume of about 193 ml.
- the aqueous phase is then centrifuge refined to eliminate solid particles passed through the filter. After solid elimination, 160 ml of crude aqueous extract, containing 1.41 g of hydroxytyrosol, with a HPLC purity of 47.5%, are obtained.
- a 0.3 m 2 membrane made of the same material is then used in order to obtain a hydroxytyrosol concentrate containing 10.8% of hydroxytyrosol with an HPLC purity of 80.53%.
- maltodextrin For example, equivalent 10 dextrose potato maltodextrin may be used.
- a peristaltic pump is used to feed the spray-dryer, which is previously equilibrated with an inlet air temperature of 150° C. The feeding speed is adjusted in order to obtain an outlet air temperature which is less than 100° C.
- a sample of 290 ml of aqueous extract containing 0.38 g of hydroxytyrosol obtained according to Example 2 and subsequently concentrated by reverse osmosis is mixed with 50 g of maltodextrin until maltodextrin was completely dissolved.
- maltodextrin for example, equivalent 10 dextrose potato maltodextrin may be used.
- a peristaltic pump is used to feed the spray-dryer, which is previously equilibrated with an inlet air temperature of 150° C. The feeding speed is adjusted in order to obtain an outlet air temperature which is less than 100° C. 48.25 g of a greyish powder, with a moisture of 6.72% (Karl Fischer) and a hydroxytyrosol richness of 0.71%, are obtained.
- maltodextrin for example, equivalent 10 dextrose potato maltodextrin may be used.
- a peristaltic pump is used to feed the spray-dryer, which is previously equilibrated with an inlet air temperature of 175° C. The feeding speed is adjusted in order to obtain an outlet air temperature which is less than 100° C. 27.1 g of a white powder, with a moisture of 5.45% (Karl Fischer) and a hydroxytyrosol richness of 0.97%, are obtained.
- a sample of 1750 l of aqueous extract containing 432 g of hydroxytyrosol obtained, according to Example 3, in a pilot plant is concentrated according to Example 6, to obtain a hydroxytyrosol concentrate containing 39.04% of hydroxytyrosol with an HPLC purity of 95.60%.
- the concentrated solution is used to feed the spray-dryer, which is previously equilibrated with an inlet air temperature of 150° C.
- the feeding speed is adjusted in order to obtain an outlet air temperature less than 100° C. 375.84 g of a light brown powder, with a moisture of 4.35% (Karl Fischer) and a hydroxytyrosol richness of 94.74%, are obtained.
- the oil-free aqueous phase about 56 L, is then centrifuge refined to eliminate solid particles passed through the Kieselguhr filter After solid elimination, 52 L of crude aqueous extract, containing 141 g of hydroxytyrosol, with a HPLC purity of 50.5%, are obtained.
- crude aqueous extract is loaded on a column containing an ion exchange resin of the anionic type, previously activated by means of acetate cycle.
- an ion exchange resin of the anionic type for example, IRA-67 may be used.
- the liquid phase recovered at the end of the column does not contain any hydroxytyrosol, which is instead continuously eluted with demineralized water until at least 90% of the initially charged hydroxytyrosol is recovered.
- the eluted phase coming from the first column is charged on a column containing an adsorption resin.
- resin XAD-1180 may be used.
- the liquid phase recovered at the end of the column does not contain any hydroxytyrosol.
- hydroxytyrosol is eluted from the resin with demineralized water until at least 90% of the initially charged hydroxytyrosol is recovered.
- the eluted phase contains approximately 114 g of hydroxytyrosol with an HPLC purity of about 96.7%.
- a 461 L fraction of purified extract containing 114 g of hydroxytyrosol obtained in a pilot plant is concentrated using a reverse osmosis pilot plant, equipped with a 2.5 m 2 polymeric membrane, in order to reduce the volume to 10 l of concentrate product.
- a 0.35 m 2 membrane made of the same material is then used, in order to obtain a hydroxytyrosol concentrate containing 3.5% of hydroxytyrosol.
- the RO concentrate is rotaevaporated at 78° C. under a vacuum pressure of 245 mbar to allow about 10 times concentration of the olive fruit extract in liquid form reaching a final concentration of 37.2% (w/w) with an HPLC purity of 93.3%.
- maltodextrin may be used.
- a peristaltic pump is used to feed the spray-dryer, which is previously equilibrated with an inlet air temperature of 150° C. The feeding speed is adjusted in order to obtain an outlet air temperature which is less than 100° C.
- 76 g of a white powder, with a moisture of 5.4% (Karl Fischer) and a hydroxytyrosol richness of 21.9% (w/w) are obtained.
- an ion exchange resin of the anionic kind for example, Diaion WA10 resin may be used.
- the liquid phase recovered at the end of the column does not contain any hydroxytyrosol, which is instead continuously eluted with demineralized water until at least 90% of the initially charged hydroxytyrosol is recovered.
- the eluted phase coming from the first column is loaded on a column containing an adsorption resin.
- resin Diaion HP20 may be used.
- the liquid phase recovered at the end of the column does not contain any hydroxytyrosol.
- hydroxytyrosol is eluted from the resin with demineralized water until at least 90% of the initially charged hydroxytyrosol is recovered.
- the eluted phase contains approximately 0.80 g of hydroxytyrosol with an HPLC purity which is higher than 95%.
- the final product because of its high purity and high hydroxytyrosol content, in particular a solid hydroxytyrosol extract free from carriers and organic solvents is highly suitable for use in the food industry, and in cosmetic and pharmaceutical industries.
- FIG. 5 is a chromatographic profile showing the separation of hydroxytyrosol and tyrosol peaks in adsorption column eluted with water. Also 2 marks are signaling the bed volumes at which sample spot 2 a and sample spot 2 b were taken.
- FIG. 6 a is a HPLC chromatogram of the sample spot 2 a (punctual sample at 2 BV) taken during collection of eluate fraction showing a complete separation of hydroxytyrosol and tyrosol in adsorption column eluted with water.
- FIG. 5 is a chromatographic profile showing the separation of hydroxytyrosol and tyrosol peaks in adsorption column eluted with water. Also 2 marks are signaling the bed volumes at which sample spot 2 a and sample spot 2 b were taken.
- FIG. 6 a is a HPLC chromatogram of the sample spot 2 a (punctual sample at 2 BV) taken during collection of eluate fraction showing
- 6 b is a HPLC chromatogram of the sample spot 2 b taken (punctual sample at 11.8 BV), showing contamination of hydroxytyrosol with tyrosol that is eluted later than hydroxytyrosol in adsorption column eluted with water.
- Collection of eluate fraction is preferably completed after 9.8 BV avoiding ratios of hydroxyrtyrosol/Tyrosol lower than 55.
- the crude aqueous extract is loaded on a column containing an ion exchange resin of the anionic type, previously activated by means of citrate cycle.
- an ion exchange resin of the anionic type for example, IRA-67 may be used.
- the liquid phase recovered at the end of the column does not contain any hydroxytyrosol, which is instead continuously eluted with demineralized water until at least 90% of the initially charged hydroxytyrosol is recovered.
- the eluted phase coming from the first column is concentrated by reverse osmosis till a final volume equivalent to 1.8 bed volumes of the adsorption resin contained at the second column.
- the reverse osmosis concentrate is charged at the second column containing an adsorption resin.
- 1000 L resin XAD-1180 may be used, then the loaded reverse osmosis concentrate is 1800 L (1.8 bed volumes).
- the liquid phase recovered at the end of the column after complete the loading phase of reverse osmosis concentrate (column permeate fraction), does not contain any hydroxytyrosol. After that, resin is washed with 1.33 bed volumes of water. Then the water elution phase starts, and the column eluate fraction is collected into the purified product tank.
- Hydroxytyrosol is eluted from the resin with 8.45 bed volumes of demineralized water (same quality that the one used for the washing step) until the HPLC analysis of a spot sample of the eluate take at outlet of the column presents a ratio hydroxytyrosol/tyrosol (w/w) lower than 15/1.
- the chromatographic profile showing the separation of hydroxytyrosol and tyrosol peaks is presented in FIG. 5 . Presence of oleuropein and aldehydic form of oleuropein aglycone is checked by HPLC but these compounds are not detectable at any moment during the elution step, being the detection limits for both compounds 500 ppm.
- the eluted phase contains approximately 7400 g of hydroxytyrosol (at least 90% of the initially loaded hydroxytyrosol) with an HPLC purity of about 95.7% and a ratio hydroxytyrosol/tyrosol (w/w) of 113/1.
- the eluted fraction of purified extract containing 7400 g of hydroxytyrosol is concentrated by reverse osmosis, in order to reduce the volume to 230 L of concentrate product.
- the RO concentrate is rotaevaporated at 78° C. under a vacuum pressure of 245 mbar to allow about 14 times concentration of the olive fruit extract in liquid form reaching a final hydroxytyrosol concentration of 41.5% (w/w) with an HPLC purity of 94.8% and a ratio hydroxytyrosol/tyrosol (w/w) of 110/1 (see FIG. 5 ) and a ratio hydroxytyrosol/hydroxymethylfurfural (w/w), of 9050 was obtained.
- Presence of oleuropein and aldehydic form of oleuropein aglycone is checked by HPLC at olive fruit extract in liquid form (final product) but these compounds are not detectable, being the detection limits for both compounds 500 ppm (see FIG. 6 a , FIG. 6 b and FIG. 7 for identification of hydroxytyrosol, tyrosol, oleuropein and aldehydic form of oleuropein aglycone, comparison of peak profile and retention time of every compound).
- hydroxytyrosol content (w/w) was 41.5% and the detection limits for oleuropein and aldehydic form of oleuropein aglycone, 500 ppm a theoretical weight ratio hydroxytyrosol/oleuropein and hydroxytyrosol/aldehydic form of oleuropein aglycone could be calculated, being the theoretical value higher than 830.
- the oleuropein of FIG. 7 is initially present in a sample of olive leaf extract purchased from Naturex; it was hydrolysed with beta-glucosidase from almond (purchased at Sigma) during 1 h at 25° C. at pH 5.0 in 100 mM sodium phosphate buffer. It is shown for comparative reasons with FIGS. 6 a and 6 b , especially to identify the retention times of oleuropein and aldehydic form of oleuropein aglycone formed during the reaction
- the ion species detected in purified olive extract in liquid form having a hydroxytyrosol concentration of 41.5% (w/w) with an HPLC purity of 94.8% and a ratio hydroxytyrosol/tyrosol (w/w) of 110/1 obtained according to Example 15 on the HPLC-DAD-MS systems are shown in FIG. 9 .
- FIG. 10 shows a chromatogram DAD (280 nm); BPC (Base Peak Chromatogram) in negative ( ⁇ ) and positive (+) ionization mode, for purified olive extract in liquid form having a hydroxytyrosol concentration of 41.5% (w/w) with an HPLC purity of 94.8% and a ratio hydroxytyrosol/tyrosol (w/w) of 110/1 obtained according to Example 15 dissolved in MeOH 0.1% HCOOH 100 mg/ml.
- DAD 280 nm
- BPC Base Peak Chromatogram
- the extension of the washing step was maintained fix (1.3 to 1.5 bed volumes), but the extension of the elution step was tested in the range 7 to 10 bed volumes, as shorter the bed volumes used for elution as higher the ratio hydroxytyrosol/tyrosol (w/w) obtaining values for such ratio from 55/1 to 618/1 ( FIG. 8 a ).
- the recovery of initially charged hydroxytyrosol at the eluted fraction is at least 80%. Presence of oleuropein and aldehydic form of oleuropein aglycone is checked by HPLC for every batch but these compounds are not detectable at any moment during the elution step nor in the final product.
- the ratio hydroxytyrosol/hydroxymethylfurfural (w/w) was calculated for the crude aqueous extract after centrifugation, but before column purification the values were in the range 45:1 to 136:1 (see FIG. 8 b ).
- maltodextrin may be used.
- the solution is pumped to feed the spray-dryer, which is previously equilibrated with an inlet air temperature of 150° C.
- the feeding speed is adjusted in order to obtain an outlet air temperature which is less than 78° C.
- a production lot of 26.2 Kg of a white powder, with a moisture of 3.4% (Karl Fischer) and a hydroxytyrosol content of 22.8% (w/w), and a ratio hydroxytyrosol/tyrosol (w/w) of 115/1 and a ratio hydroxytyrosol/hydroxymethylfurfural (w/w), of 9136 were obtained.
- the chromatographic separation is performed on a rapid resolution C18 column 50 ⁇ 3.0 mm, 1.8 ⁇ m under gradient conditions.
- the mobile phase consists of a mixture of methanol and water, both containing 0.1% of formic acid, with the aim of promoting the ionization of the compounds in samples.
- the signals are registered in a diode array detector (at 280 nm) and in a TOF mass spectrometer detector with an electrospray ion source (ESI).
- a diode array detector at 280 nm
- ESI electrospray ion source
- an ion trap mass analyzer has been used with the aim of elucidating and confirming the molecules structures, which has been previously identified in the RRLC-TOF system.
- a C18 column 150 ⁇ 2.1 mm, 3.5 ⁇ m is used under gradient conditions, because d the system cannot work at pressures above 400 bars.
- the rest of chromatographic conditions are the same as those described in the previous section.
- FIG. 9 shows the results obtained with IT and TOF mass analyzers. In both cases, the ionization has been carried out in negative and positive polarity. Therefore, the ions obtained in each ionization mode are shown in the table attached to the ionic species detected.
- the capsules were automatically cleaned externally and filled into a blistering machine that produces the blisters with 30 capsules. Finally blisters were manually introduced into the final packing.
- the objective of the study was to analyze the protection of blood lipids from oxidative stress due to the intake of the oral compositions of olive oil added with a hydroxytyrosol-rich olive extract in a human intervention study by measuring the serum levels of oxidized LDL.
- Body mass index (BMI) between 18.5 and 30 kg/m 2
- Diabetes mellitus or other serious chronic disease including allergies and severe psoriasis at the time of the study or before that
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Hydroxytyrosol extracted from olives and/or from the solid residues of olives after the extraction of olive oil, by acid hydrolysis and purification on resin columns eluted with water contains hydroxytyrosol and tyrosol, is free from sugars, has a residual content of Benzo[a]pyrene that is less than 2 microg/Kg (weight BaP/weight of extract as dry matter), containing a weight ratio of hydroxytyrosol to hydroxymethylfurfural of between 45:1 and 10000:1, and the content of hydroxytyrosol in the extract is at least 0.5% (w/w) with purity of at least 40% (by HPLC 280 nm).
Description
- This application is a Continuation-in-Part of U.S. patent application Ser. No. 12/524,603, filed Dec. 15, 2009. The contents of this application is incorporated herein by reference.
- The present invention relates to a hydroxytyrosol containing extract obtained from olives and/or the solid-containing residues of olives after the extraction of olive oil. More particularly, the invention relates to the production of hydroxytyrosol-containing extracts to be used as a source of hydroxytyrosol in food, medical and cosmetic industries.
- It is now well known that olives contain a number of bioactive compounds, particularly polyphenols; among these polyphenols, hydroxytyrosol is of outstanding biological significance in view of its antioxidant, antimicrobial and radical scavenging activity.
- Hydroxytyrosol is present in olives and olive oil and has the following formula:
- In co-pending patent applications EP07001791 and PCT/IB2008/000173, which are incorporated by reference, process and apparatus for the production of hydroxytyrosol from olives and/or olive oil extraction residues are described, which aim at the production of hydroxytyrosol-containing products or extracts to be used as a source of hydroxytyrosol in food, medical and cosmetic industries. The content of the above applications is hereto incorporated by reference.
- Production of hydroxytyrosol from olives residues after oil extraction was and is actively investigated; an efficient extraction process could be very profitable especially because the major amount of hydroxytyrosol and hydroxytyrosol precursors initially present in the olives remains in the residues from olive oil production and only a minor part is found in the oil. Extra virgin olive oil normally contains 1-20 ppm of hydroxytyrosol.
- The residues of olive oil extraction of interest for the present application exclude the olive tree leaves, because the leaves are removed before oil extraction. Moreover, hydroxytyrosol extraction from leaves faces different starting compositions (and therefore different extraction problems) than extraction from olives or olive residues.
- The residues of olives as obtained from olive oil extraction processes of interest for the present application can be classified as:
-
- pomaces, i.e. the solids containing residues of the pressing (in Spanish: orujo), of the three-phases process (orujo), or of the two-phases process, in which no water is added to the chopped olives in the centrifugation step (in Spanish: alperujo). Orujo, alperujo and defatted orujo contain a high amount of water (45% to 70%). Extraction residues also comprise orujillo, the olive dry solids, after orujo oil extraction that contains less than 15% water and is nearly free from oil residues.
- The green olives extracts of the invention are preferred to the extracts of residues of olive oil production in view of their greater amount of hydroxytyrosol and of the reduced content of hydroxymethylfurfural.
- For the purposes of the present description the term “pomaces” or “solid residue” is designating both “orujo”, “defatted orujo” “orujillo” and “alperujo”. Preferred starting materials for the present invention are olives, more preferably green olives, and pomaces.
-
- It is well known that several sensory properties are elicited by olive polyphenols in extra virgin and virgin olive oils. The sensory aspect of these olive oils has great repercussions on its acceptability by consumers. Some phenols mainly elicit the tasting perception of bitterness; however, other phenolic molecules can stimulate the free endings of the trigeminal nerve located in the palate and also in the gustative buds giving rise to the chemesthetic perceptions of pungency, astringency and metallic attributes.
- Oleuropein, the phenolic compound that makes the fruit of the olive bitter, is water-soluble rather than fat-soluble, and it gets poorly transferred into the oil when the fruit is pressed, thus average content of oleuropein in extra virgin and virgin olive oils is from 1 ppb to 11 ppm.
- Oleuropein is present in olives and olive oil and has the following formula:
- Nevertheless, a number of oleuropein related compounds are more oil soluble than oleuropein itself, and do end up at a higher content in the oil, in the form of isomer (or isomers) of oleuropein aglycone (e.g.: aldehydicic form of oleuropein aglycone, AOA), and dialdehydic form of elenolic acid linked to hydroxytyrosol or tyrosol, respectively named 3,4-DHPEA-EDA and p-HPEA-EDA, that are the olive polyphenols mainly responsible for the bitter taste according to Gutierrez-Rosales and co-authors, J. Agric. Food Chem. 2003, 51, 6021-6025.
- Oleuropein aglycone (e.g: aldehydic form of oleuropein aglycone) is present in olive oil and in crushed olives during oil extraction process and has the following formula:
- It is known to carry out acid hydrolysis of the pomaces (or of vegetation water) to have the cleavage of the ester bond in the oleuropein molecule and obtain hydroxytyrosol.
- U.S. Pat. No. 6,361,803, which is incorporated by reference, discloses extraction of hydroxytyrosol (and other compounds) by neutral or acid hydrolysis of olive pulp residues at reflux for one hour (ex.12). The extracted water solution is loaded on an absorption XAD-7 column that is eluted with methanol to recover the extracted hydroxytyrosol. U.S. Pat. No. 6,361,803 requires the use of organic polar solvents, to recover hydroxytyrosol with a minimum purity grade, in addition (ex.12) freeze precipitation of some impurities from the methanol solution is necessary. Polar aqueous solvents are selected among methanol, ethanol, acetonitrile or acetone, while polar organic solvents are selected, for example, among esters, amides, dimethyl sulfoxide, dioxane, DMF and their mixtures. Most of these solvents are toxic and very difficult to completely eliminate from the desired hydroxytyrosol product. Accordingly, traces of the utilized solvents will be found in the final product even after several purification steps, thus rendering the hydroxytyrosol obtained according to this process not suitable for a safe application in the alimentary, cosmetic and pharmaceutical field. Moreover, the final product is not suitable for use in fortifying foods, particularly edible oils, without use of ethanol and acetic acid as additives to the extract to obtain a stable food product: the resulting food product (oil plus hydroxytyrosol containing extract, ethanol and acetic acid) is not acceptable in the food industry.
- WO 2004/005228, which is incorporated by reference, discloses hydrolysis at room temperature of vegetation water obtained from olive oil extraction by incubation of the acidified vegetation water for at least two months and preferably 6-12 months until at least 50% (preferably 90%) of the oleuropein originally present in the vegetation water has been converted to hydroxytyrosol. The incubated vegetation water is extracted with an organic solvent, for example ethyl acetate, or it is contacted with a supercritical fluid (CO2), to produce a fraction rich in hydroxytyrosol. The main problems of this process are the very long time required for the incubation of the acidified vegetation water and the use of organic solvents, that should be avoided, particularly when the final product obtained is to be used in the alimentary, cosmetic and pharmaceutical field.
- U.S. Patent Application Publication 2004/0102657, which is incorporated by reference, discloses acidic hydrolysis with a steam explosion process at high temperatures (about 190-220° C.). The obtained solution is firstly partially purified on a column with non activated ion exchange resin and subsequently loaded on a XAD non-ionic column, from where the hydroxytyrosol is eluted with methanol or ethanol. The process results in a poor yield in hydroxytyrosol, considering the process in its entirety.
- EP 1623960, which is incorporated by reference, 0, discloses a process of recovery of hydroxytyrosol, and tyrosol, from alpechin by means of filtration in a complicated plant consisting of three units (Ex. 1) and subsequent separation. The tyrosol is then oxidated to hydroxytyrosol in a protic solvent (alcohol or water) to obtain a final product that is semi-synthetic. Additionally, EP 1623960 discloses that concentration by nanofiltration and reverse osmosis of vegetation waters (alpechin) are carried out at neutral or alkaline pH (claim 4). This process has two important problems. A first drawback is that hydroxytyrosol degradation increases at neutral and alkaline conditions giving unwanted products that are difficult to remove, and, in addition, due to the fact that no acid hydrolysis is carried out the oleuropein content should be still high. Secondly, the obtainable concentration factor is poor, thus the maximum concentration allowed for hydroxytyrosol according Ex-1 (see table 1) is in the range from 1.2 to 1.6 g/L.
- U.S. Patent Application Publication 2004/0176647, which is incorporated by reference, discloses an extraction process of phenols from alperujo under stirring at 180-240° C. in autoclave, in water. No acid is added, but the thermal treatment results in a “liberation of acetyl groups” and in an alleged consequent reduction of the pH (
page 3, first paragraph). Nevertheless, at the pHs produced in the described conditions hydrolysis of oleuropein is far to be complete, meaning two things, lower hydroxytyrosol yields and remaining hydrolysed oleuropein, that as we discuss above is causing non-pleasant taste in food products containing such extracts, that are thus not suitable for food applications. The products are tyrosol and hydroxytyrosol, that are separated by HPLC with sulphuric acid/acetonitrile eluent. - Summarizing, the above mentioned techniques are either too long or too complex, or too harsh, or all of the above; this results in that the amount of remaining oleuropein, i.e. the amount that is not hydrolyzed, and/or the amount of the hydrolysis by-products such as hydroxymethylfurfural is high enough to make difficult the subsequent purification steps.
- Obtaining a good source of hydroxytyrosol is very important for the fortification of foods, especially of edible oils. Extracts should not transfer to oils any bitter polyphenolic substances, however, the health beneficial compounds, namely hydroxytyrosol, are always associated to bitter polyphenols in the known extracts.
- Frank and co-authors in J. Agric. Food Chem. 2001, 49, 231-238 disclose a procedure called “taste dilution analysis” in order to point out the sensory threshold of bitter for oleuropein derivatives. Bitterness was assessed by preparing serial dilutions of samples in water and then tasting them according to increasing concentration, until the concentration at which the diluted sample can be differentiated from water as judged in a triangle test is found.
- It was also shown that at least for these compounds there is no direct correlation of bitterness with the absorbance at 225 (the K225 value): Mateo et al. J. Am. Oil Chem. Soc. 2004, 81, 71-75, verified the correlation between the aldehydicic form of oleuropein aglycone (obtained by hydrolysis of oleuropein with β-glucosidase from almonds purchased from Sigma) and bitterness.
- Andrewes et al., J. Agric. Food Chem. 2003, 51, 1415-1420, assessed the relationship between polyphenols and olive oil pungency; p-HPEA-EDA was the key source of the burning sensation found in many olive oils.
- In 2005, Beauchamp and co-authors, Nature 2005, 437, 45-46, measured the pungent intensity of p-HPEA-EDA isolated from different extra virgin and virgin olive oils confirming this molecule is the principal agent in extra virgin and virgin olive oils responsible for throat irritation.
- Additionally, the bitter and pungent polyphenols present in olive oil, are also presents in olives and are also responsible for their bitterness and pungency, those being the ones that best correlate with the bitterness attribute the oleuropein and the aldehydic form of oleuropein aglycone. The crushing of olives to prepare olive oil or olive extracts produces the hydrolysis of oleuropein by endogenous β-glucosidase rendering oleuropein aglycone as transient specie that forms the aldehydic form of oleuropein aglycone. Thus, the use of olive extracts containing oleuropein and/or the aldehydic form of oleuropein aglycone can modify the taste of foods in which the aforementioned extract is incorporated, resulting in a lower acceptance by consumers.
- Summarizing, any way set up in order to increase antioxidant capacity using techniques based on fortification of foods with olive polyphenols, should not alter food natural organoleptic characteristics, nor increase the amount of the bitter tasting olive polyphenols, otherwise incurring with the subsequent alteration of organoleptic properties of the food, thus causing non-pleasant taste due to excessive bitterness, pungency and/or astringency, and subsequently causing rejection of the fortified food from many consumers.
- It is known to add polyphenols and hydroxytyrosol to food products.
- U.S. Pat. No. 6,942,890 which is incorporated by reference, discloses a method of fortifying food products adding to such products solid matter derived from olive fruits, resulting in an increase of the level of antioxidants, particularly of olive polyphenols.
- It has also to be noted that all the previously mentioned techniques allow to obtain a fortified food with an increased content of total olive polyphenols but with a low content in hydroxytyrosol with respect to the total olive polyphenols content, due to the fact that most of the polyphenols incorporated to the fortified food are secoiridoids, oleuropein related compounds as oleuropein aglycone (AOA), 3,4-DHPEA-EDA and p-HPEA-EDA, at a higher content than hydroxytyrosol, and that those olive polyphenols are mainly responsible for the bitter taste and pungency of the fortified oil. The incorporation of these secoiridoids, able to produce undesirable changes in the organoleptic properties of the fortified food, is in fact directly related with the source of olive polyphenols used in all the previously mentioned techniques, which in fact present a low content in hydroxytyrosol and/or a low purity degree.
- A few studies addressed the bioavailability of polyphenolic compounds in olive showing that the absorption of olive oil phenolics is probably larger than 55-66 mol %, and that the absorption of hydroxytyrosol is dose-dependent, suggesting that olive oil phenolics are absorbed from the intestine, that tyrosol and hydroxytyrosol are incorporated in lipoprotein fractions, and that hydroxytyrosol is excreted in urine as glucuronide conjugate. The incorporation of phenolic compounds from olive oil in LDL particles has been proposed as the mechanism by which olive phenolics may protect LDL particles from peroxidation.
- The EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) concludes that a cause and effect relationship has been established between the consumption of olive oil polyphenols (standardized by their content of hydroxytyrosol and its derivatives) and protection of blood lipids from oxidative stress.
- According to Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 Dec. 2006 on nutrition and health claims made on foods, a claim that a food is sugars-free, and any claim likely to have the same meaning for the consumer, may only be made where the product contains no more than 0.5 g of sugars per 100 g or 100 ml.
- It is an aim of the present invention to solve the above mentioned problems and to provide olive extracts to be used as a source of hydroxytyrosol to prepare fortified food oils and products in general and dietary supplements for protection of blood lipids from oxidative stress, thus preventing or treating cardiovascular diseases, plaque build-up in the arteries, arterial hypertension, and metabolic syndrome, but avoiding non-pleasant alterations of organoleptic properties of the fortified foods.
- In fact, the applicant found that generation of by-products is a much bigger problem in the production of hydroxytyrosol extracts than it was previously thought, as it appears from the above discussed prior art documents: the starting materials, especially olives and pomaces, contain inter alia a high amount of phenolic compounds in the form of glucoside and/or its esters including oleuropein, ligustroside, verbascoside and several flavonoids. Several other natural compounds are present. It is very easy to degrade the starting compounds into a plethora of by-products.
- As by-products must be eliminated to purify hydroxytyrosol, in the known art the use of organic solvents is required in order to purify the hydroxytyrosol during the subsequent purification steps on chromatographic columns. The use of organic solvents, for example methanol, when eluting from a resin column, is inconvenient, particularly when the final product obtained is to be used in the alimentary, cosmetic and pharmaceutical field.
- Moreover, the known hydroxytyrosol-rich extracts are not suitable to be used as additives for foods, especially edible oils.
- Therefore, there is the need for a hydroxytyrosol containing extract that is rich in hydroxytyrosol and has low content of starting products and of bitter products such as oleuropein and verbascosides, and of by-products, particularly hydroxymethylfurfural and in general has a very low content in sugars and in salts.
- It is an aim of the present invention to solve the above mentioned problems and to provide a hydroxytyrosol extract from olives and/or olive oil extraction by-products that is simple to obtain, not expensive and that is a high purity product free from organic solvents and suitable for use as additive for food, cosmetics etcetera.
- Such aim is achieved by means of the present invention that provides an extract, as obtainable by extraction from a starting material selected from olives and/or pomaces, residues of olives after the extraction of olive oil, characterized in that said extract contains hydroxytyrosol and tyrosol, the amount of sugars per 100 g or 100 mL of extract is 0.5 g or less, the residual content of Benzo[a]pyrene in said extract is less than 2 microg/Kg (weight BaP/weight of extract as dry matter), containing a weight ratio of hydroxytyrosol to hydroxymethylfurfural of between 45:1 and 10000:1 and in that the content of hydroxytyrosol in said extract is at least 0.5% (w/w) and the hydroxytyrosol purity is at least 40% (by
HPLC 280 nm). - More particularly, a preferred olive extract is that one obtained according to the process hereinafter disclosed, having a content in hydroxytyrosol of at least 0.5% by weight (w/w), and a purity of hydroxytyrosol of at least 40% (by HPLC at 280 nm). This extract is free of organic solvents (the residual content of organic solvents is less that 1 ppb and preferably 0 ppm) and substantially free of sugars, and the content in hydroxytyrosol of that extract is at least 0.5% (w/w) and the purity of hydroxytyrosol is at least 40% (by HPLC at 280 nm). A hydroxytyrosol content of at least 10% (w/w) is preferred, and more preferably at least 35% (w/w); the purity of hydroxytyrosol at 80% is preferred, and more preferably at 90% (by HPLC at 280 nm).
- The substantial absence of even minimal traces of organic solvents such as methanol, ethanol, isopropanol that are employed in the purification steps of the prior art, is of great importance for the intended use of the aforementioned extracts.
- Additionally, some of the polyphenols present in olives are responsible for their bitterness, the ones that best correlate with this attribute being the oleuropein and the aldehydic form of oleuropein aglycone. Thus, the use of olive extracts containing oleuropein and/or the aldehydic form of oleuropein aglycone can modify the taste of foods in which the aforementioned extract is incorporated, resulting in a lower acceptance by consumers.
- Olive extract rich in hydroxytyrosol obtained according to the invention process (as per co-pending U.S. application Ser. No. 12/524,603) is virtually free of oleuropein and of the aldehydic form of oleuropein aglycone, the total amount of each compound being less than 500 ppm (their detection limit), because no organic solvent is used, where these molecules, much more hydrophobic than hydroxytyrosol, are more soluble, for obtaining the extract, together with the combination of purifying steps used, chromatographic columns, for obtaining the extract.
- Also the olive extract rich in hydroxytyrosol obtained according to the invention process has a very low content of hydroxymethylfurfural, being the ratio hydroxytyrosol/hydoxymethylfurfural (w/w) higher than 45:1 before column purification or higher than 9000:1 after purification steps, because the controlled extraction conditions pH time and temperature, together with the combination of purifying steps used, chromatographic columns, for obtaining the extract.
- An additional advantage of the above mentioned olive extracts is the purification from the residues of pesticides present in raw materials, i.e. in the olives and olive pomaces. Thus, potentially toxic chemicals such as insecticides, herbicides, fungicides, rodenticides, etc. . . . , such as: diuron, terbuthylazine, simazine, α-endosulfan, and β-endosulfan may be present in the starting material.
- Hydroxymethylfurfural (HMF), also 5-(Hydroxymethyl)furfural, is an organic compound derived from dehydration of certain sugar, especially in acidic conditions. This yellow low-melting solid is highly water-soluble. The molecule consists of a furan ring, containing both aldehyde and alcohol and functional groups. HMF has been identified in a wide variety of heat-processed foods including milk, fruit juices, spirits, honey, etc. . . .
- HMF is a natural component in heated food but is usually present in low concentrations. The daily intake of HMF may underlie high variations due to individual consumption-patterns. It has been estimated that in a western diet, about 5-10 mg of HMF are ingested per day from food.
- In former times, HMF was used in food for flavoring purposes, but in Europe this practice now is suspended. HMF is also found in cigarette smoke.
- In vitro tests and studies on rats suggest potential toxicity and carcinogenicity of HMF. In humans, no correlation between intakes of HMF and disease has yet been demonstrated.
- Polycyclic aromatic hydrocarbons (PAHs), are potent atmospheric pollutants that consist of fused aromatic rings and do not contain heteroatoms or carry substituents. PAHs occur in oil, coal and tar deposits, and are produced as byproducts of fuel burning (whether fossil fuel or biomass). As a pollutant, they are of concern because some compounds have been identified as carcinogenic, mutagenic and teratogenic. PAHs are also found in cooked foods. Studies have shown that high levels of PAHs are found, for example, in meat cooked at high temperatures such as grilling or barbecuing, and in smoked fish. As olive oil extraction residues are complex materials it is possible that harsh conditions in temperature (i.e. steam explosion extraction) during olive polyphenol extraction could produce such PAHs at residual levels, being then desirable that a process to extract olive polyphenols avoid such PAHs residual levels formation.
- Benzo[a]pyrene (BaP) is commonly used as an indicator species for PAHs contamination and most of the available data refer to this compound.
- AIIs, HMF, PAHs and above mentioned pesticides have molecular structures (e.g. the core of triazines in most of the pesticides) capable of interacting with the absorption resins and then are eluted from the resin together with other components of the extract when using organic solvents. Thus the methods of preparing extracts from olives based on the use of an absorbent resin and subsequent elution with organic solvents must exercise extreme quality control on the raw material pesticide residues, but also in the hydrolysis and extraction process of olive polyphenols in acidic conditions from olive materials containing sugar able to degradate to HMF, since the absorption resin can act as a trap for PAHs, HMF and these pesticides, that will concentrate on the resin and then elute when an organic solvent is used to recover the hydroxytyrosol present in the olive.
- The above problem was solved by the invention with the preparation of an olive extract rich in hydroxytyrosol, due to the fact that the non-ionic absorption resins were specifically selected to elute the active compounds of the said extract by use of water only, or of an aqueous solution basified and not by the use of organic solvents.
- The process of preparing the extract of the invention entails the acidic hydrolysis in water of the starting materials at a temperature not exceeding 140° C., preferably within the range from 70° C. to 130° C. and most preferably above the reflux temperature, in the range of 110° C. to 130° C. and in a pressurized condition, e.g. in an continuous sterilization system, at a pressure within the range of atmospheric pressure to 10-20 psi above the atmospheric pressure. The pH of the acidified mixture that undergoes the hydrolysis is within the range of 1.0 to 6.0. The mixture after the hydrolysis is clarified by physical methods known in the art, e.g. by filtering and/or centrifuging, to remove the suspended solids from the hydrolysis water solution, and to obtain a clarified solution substantially free of solids in suspension.
- The starting materials are olives or pomaces, i.e. the above defined residues from olive oil extraction. Preferred olives are green olives, pomaces are preferably free from oil. Oil is removed either before or after the hydrolysis step by means known in the art (e.g. those used to prepare defatted orujo or orujillo) or by use of diatomaceous earth or other filter means.
- According to the invention the above steps (acid hydrolysis and clarification) are followed by the steps of loading the product thus obtained in at least one chromatographic column of an acid activated anion exchange resin, and of eluting the products retained in said chromatographic column with water.
- In a preferred aspect, the invention provides for a further purification step carried out by loading the water-eluted solution from the first column (anion exchange) in at least one chromatographic column of adsorbent non-ionic resins and of eluting the products retained in said second chromatographic column with water.
- According to a further aspect of the invention the liquid product is concentrated e.g. by reverse osmosis concentration. According to a further step, after chromatographic purification and reverse osmosis concentration, the resulting liquid product is brought to a solid form, e.g. by freeze-drying, vacuum rotaevaporation or spray drying, with or without carriers such as maltodextrines.
- The extract of the invention has a ratio by weight of hydroxytyrosol:oleuropein that is greater than 200:1, preferably also a ratio (by weight, i.e. w/w) of hydroxytyrosol: aldehydic form of oleuropein aglycone that is between 5:1 and 850:1.
- Additionally, in a preferred embodiment the extract according to the invention is free from oleuropein and aldehydic form of oleuropein aglycone (by
HPLC 280 nm). - According to another aspect, the invention extract has a ratio hydroxytyrosol:tyrosol that is greater than 55:1 by weight, preferably within the range of 55:1 to 618:1.
- Moreover, the extract is free from organic polar solvents.
- A further object of the invention is the use of an extract as above disclosed as a source of hydroxytyrosol in the food industry as additive or as functional ingredient; as a source of hydroxytyrosol in the cosmetic industry or as a source of hydroxytyrosol in the pharmaceutical industry. To put it in other words, it is an object of the invention a process of preparing an enriched food, cosmetic or pharmaceutical product, wherein an extract according to the invention is added to said product.
- The invention provides several advantages over the prior art techniques.
- First of all, the hydrolysis step is carried out, according to the present invention, using just water and mineral acid, keeping the temperature in the claimed range preferably above the reflux temperature, using a combination of heating and pressure. When pressure is applied together with the claimed heating temperature, the resulting hydrolysis reaction is almost completed in about half an hour, without significant formation of by-products and with a very good conversion of the starting material (oleuropein) into the final desired product (hydroxytyrosol). The hydrolysis step according to the present invention allows to obtain, in a short time, a very good yield in hydroxytyrosol together with a quite complete absence of those by-products, that are difficult to eliminate and which are instead formed, according to the prior art, in significant amounts.
- The hydrolysis step, carried out according to the invention, provides for another advantage. The combined use of acids and temperature, beside its main objective, that is to carry out the hydrolysis with a good conversion rate and avoiding the formation of detrimental by-products, results in a sterilization of the mixture. In fact, the hydrolysis step provides a sterilization of the water solution, i.e. of the products involved, that is very useful, as the starting material (for example pomaces) used in the processes for the preparation of hydroxytyrosol, usually comes from already treated materials, and generally requires some depuration-sterilization pre-treatments, to give a safe hydroxytyrosol final product. Said depuration-sterilization pre-treatments are often complex treatments and require additional process steps that, at the end of the full process, result in a lower yield in the desired final product. According to the present invention, the hydrolysis step contemporaneously allows to carry out the hydrolysis reaction and provides for the necessary sterilization of the products involved, thus avoiding the necessity to carry out any sterilization step on the starting material as well as providing for a hydrolysed material that is ready for further uses, without any additional sterilization treatment.
- In addition, the hydrolysis step is followed by at least a purification step, which is carried out by loading the product obtained from the hydrolysis step in at least a single chromatography column system or in a two chromatography columns system and eluting the hydroxytyrosol retained in said chromatographic columns with water. In this case, as there are very low amounts of by-products coming from the hydrolysis step, it is possible to make use of a chromatographic column that can be eluted with water in the absence of any organic solvent, either alone or mixed with water. This means that no organic solvents are contacted with the hydroxytyrosol, thus obtaining a purified hydroxytyrosol that is particularly suitable to be used in the alimentary, cosmetic and pharmaceutical field.
- Another advantage of the present invention is due to the concentration step, that allows to enrich the hydroxytyrosol content after the purification steps. These purification steps produce a liquid extract, substantially free from sugars and salts, resulting in a very important reduction of the osmotic pressure during the concentration step of the purified liquid extract permitting thus a very high concentration factor (until 350 times). This concentration step provides a “concentrate” characterized by a high content of hydroxytyrosol, which can be directly used for further treatments. According to the prior art, where no “concentration” steps are usually provided or when provided they have poor concentration factors (about 2 to 5 times) due to the lack of a previous purification that removes sugars and salts, in the described processes for hydroxytyrosol preparation, the hydroxytyrosol concentration in the processed solutions/dispersions is always very low, thus resulting in the necessity to operate with great volumes with consequent lower yields in the final product.
- Always according to the present invention, the possibility to obtain a solid final product that is not mixed with any carrier, for example maltodextrines, gives the opportunity to formulate purified hydroxytyrosol according to its final intended use and according to any formal requirement, possibly required.
- As above mentioned, an additional advantage of the invention's olive extracts is the purification from the residues of pesticides present in raw materials, i.e. in the olives and pomaces.
- The invention will now be further disclosed in greater detail with reference to the enclosed non-limiting drawings wherein:
-
FIG. 1 is a schematic view of an apparatus according to an exemplary embodiment of the invention; and -
FIGS. 2-4 are chromatograms of three hydroxytyrosol containing products according to three embodiments of the invention process. -
FIG. 5 is a chromatographic profile showing the separation of hydroxytyrosol and tyrosol peaks in adsorption column eluted with water. Also 2 marks are signaling the bed volumes at whichsample spot 2 a andsample spot 2 b were taken. -
FIG. 6 a is a HPLC chromatogram of thesample spot 2 a (punctual sample at 2 BV) taken during collection of eluate fraction showing a complete separation of hydroxytyrosol and tyrosol in adsorption column eluted with water. -
FIG. 6 b is a HPLC chromatogram of thesample spot 2 b taken (punctual sample at 11.8 BV), showing impurification of hydroxytyrosol with tyrosol that is eluted later than hydroxytyrosol in adsorption column eluted with water. - Collection of eluate fraction is completed after 9.8 BV avoiding ratios of hydroxyrtyrosol/Tyrosol lower than 55.
-
FIG. 7 is a chromatogram of hydrolysis reaction of oleuropein. -
FIG. 8 a is a graphical representation of ratio hydroxytyrosol/tyrosol (w/w) in 17 different production lots of olive extracts production from orujillo. -
FIG. 8 b is a graphical representation of the ratio hydroxytyrosol/hydroxymethylfurfural (w/w), at the crude aqueous extract after centrifugation in 17 different production lots of olive extracts production from orujillo. -
FIG. 9 shows the ion species detected in purified olive extract in liquid form having a hydroxytyrosol concentration of 41.5% (w/w) with an HPLC purity of 94.8% and a ratio hydroxytyrosol/tyrosol (w/w) of 110/1 obtained according to Example 15 on the HPLC-DAD-MS systems. -
FIG. 10 is a Chromatogram DAD (280 nm); BPC (Base Peak Chromatogram) in negative (−) and positive (+) ionization mode, for purified olive extract in liquid form having a hydroxytyrosol concentration of 41.5% (w/w) with an HPLC purity of 94.8% and a ratio hydroxytyrosol/tyrosol (w/w) of 110/1 obtained according to Example 15 dissolved in MeOH 0.1% HCOOH 100 mg/ml. -
FIG. 11 is a graphical representation of a number of capsules vs. net weight of olive extract inside the dietary supplement. -
FIG. 12 is a graphical representation of the plasmatic level of oxidized LDL in the participants of thegroups Group 2 with thecontrol Group 1, p<0.01 (Tukey's Test). - With reference to
FIG. 1 , the invention apparatus comprises a means, or reactor, 1, preferably a continuous sterilization system, in which the hydrolysis according to the invention process is carried out. - As previously mentioned, the hydrolysis is carried out at a temperature that does not exceed 140° C., in a reactor. Preferably the temperature range is 70 to 130° C. and most preferably it is above reflux temperature, in a range 110 to 130° C., at a pressure of 10 to 20 psi above the atmospheric pressure and for a time length within the range of 15 to 45 minutes. Preferably, the hydrolysis temperature is within the range of 118 to 126° C. and in the most preferred embodiment the hydrolysis is carried out at 120-121° C., at 15 psi (over the atmospheric pressure) for 30 minutes. A preferred reactor is a continuous sterilization system.
- The
continuous sterilization system 1 is provided with feeding means 2 for feeding to it the starting materials, namely the residues, or by-products, of olive oil extraction, namely pomaces (i.e. the solid residues of the pressed olives). -
Continuous sterilization system 1 is suitable to treat the starting materials in a continuous process rather than batchwise. Heating means 3 for heating thereactor 1 to the above mentioned temperatures are provided in a known way, e.g. as a jacket around the reactor.Reactor 1 is also provided with a supply ofdemineralized water 4 and withmeans 6 to stir the water mixture of starting product. Usually, the ratio water to solids is within the range of 1:1 to 4:1. - The hydrolysis process is carried out at a pH of 1.0 to 6.0, preferably of 1.0 to 3.0. The required amount of acid, preferably sulphuric acid, is obtained from
acid tank 5. - The combination of acidic conditions and of temperature in the claimed ranges results in a hydrolysis process that is fast and efficient and can last for 30 minutes only, at 120-123° C. and a pressure of 15 psi above the atmospheric pressure. Moreover, the process also results in the sterilization of the hydrolysis products.
- The outlet of continuous sterilization system, i.e. reactor, 1 is connected with a
filter 7 for removing solids from the reaction mixture containing hydroxytyrosol and other phenols. The filtered portion is then sent to a further separation means, preferably acentrifuge 8, where further solids are removed from the reaction mixture to obtain a liquid substantially free from suspended solids, i.e. a solution that is suitable for the following purification. The clarified liquid after centrifugation has a brownish color and is preferably stored inreservoir 9. The clarified liquid A is now containing hydroxytyrosol, a residue of oleuropein and minor amounts of phenols and other products.FIG. 2 chromatogram shows the composition and the percent of the detected compounds in this liquid and is obtained by HPLC at 280 nm; the major peak at 9.317 minutes is hydroxytyrosol and the peak at 13.150 minutes is tyrosol. - According to a preferred embodiment of the invention, liquid A is concentrated by evaporation or tangential flow filtration (TFF), (e.g. by using a reverse osmosis system). The concentration step can be carried out on liquid A directly or, preferably, after a purification step by means of at least one chromatographic column. To this end, storage tank, or reservoir, 9 is connected with means of concentrating 10, e.g. by TFF or preferably by reverse osmosis, and to purification means.
- Purification means comprises in one embodiment a single column system comprising a chromatographic column of a resin selected from acid activated anion exchange resins. In another preferred embodiment purification means comprises, in addition to the above mentioned first column of acid activated anion exchange resins at least a further, second, chromatographic column of a resin selected from adsorbent non-ionic resins.
- In another more preferred embodiment, the acid activated anion exchange resin is a weakly basic anion exchange resin, and the adsorbent non-ionic resin is a macroreticular cross-linked aromatic polymer.
- The anion exchange resins used as a chromatographic resin for the purification of hydroxytyrosol of the present invention are not particularly limited so long as they can be acid activated. Examples of preferred weakly basic anion exchange resins include polyamine-type resins (including polyamine-type chelating resins) such as reaction products of a styrene/divinylbenzene copolymer and diethylenetriamine or other, and resins as polymerization products of compounds mainly comprising allylamine, vinylamine or other; and acrylic resins such as copolymers of divinylbenzene and amide compounds which comprise acrylic acid or methacrylic acid and dimethylaminopropylamine or other. Other resins may also be used in which the aforementioned weakly basic anion exchange resin is partly substituted with strongly basic exchange groups such as trimethylamine, dimethylethanolamine or other. More specifically, known in the art resins which have been used so far can be used, for example, Diaion WA10, WA20, WA21 and WA30 (Mitsubishi Chemical), Amberlite IRA-35, IRA-67 (IRA-68), IRA-93ZU, IRA-94S, IRA-478 (Rhöm & Haas), WGR-2 (Dow Chemical) and other.
- According to the invention process, these resins are acid activated before being used, preferably with acetic acid. These resins are particularly suitable for the invention process in view of their low cost and of the fact that they can be regenerated in mild conditions. Additionally, the weakly basic nature of the resin allows the partial separation of hydroxytyrosol and tyrosol molecules. From the comparison of the peak ratio hydroxytyrosol/tyrosol and the HPLC purity of the hydroxytyrosol peak of
FIGS. 2 and 3 , it can be appreciated the efficiency of the chromatographic separation according to the invention. - In fact, the use of a weakly anionic exchange resin allows to separate very similar compounds during the elution, this is not possible by the prior art techniques using strong anionic exchange resins, because the elution of such resins is generally an all-or-nothing process. As previously mentioned, a further advantage is that the retained products can be eluted with water, without using any polar solvent such as methanol.
- Suitable adsorption resins are based on non-ionic, hydrophobic, macroreticular cross-linked aromatic polymer. Such resins are typically aromatic polymers, such as styrene and divinylbenzene copolymers, which may be cross-linked. Such resins are known and are generally prepared by polymerization of the appropriate monomers. The adsorption resins used as a chromatographic resin for the purification of hydroxytyrosol of the present invention are not particularly limited so long as they can be water eluted. Examples of preferred adsorption resins include: Amberlite® XAD-4, XAD-7, XAD-1180, XAD-16 and XAD-1600 (available from Rohm & Haas); XUS-40323.00, XUS-40285.00 and XUS-40283.00 (available from Dow Chemical Co.); and SP-700, SP-825, SP850,
Diaion HP 10,HP 20,HP 30,HP 40 and HP 50 (available from Mitsubishi Chemical). - These type of resins are particularly suitable for the invention process in view of their very high adsorption capacity for hydroxytyrosol and of the fact that, thanks to the low content of by-products in the solution obtained after hydrolysis, the adsorbed hydroxytyrosol can be recovered by elution with water, only, without any polar solvent such as methanol or ethanol, as was instead required by the prior art techniques. Adsorbed hydroxytyrosol is recovered substantially quantitatively.
- In the shown preferred embodiment, the process of the invention provides for a two-step purification on chromatographic columns.
- Liquid A, as obtained from the initial steps a) and b), i.e. hydrolysis and solid separation, is charged into
column 11, containing theanion exchange resin 12 as above detailed. The permeate is sent to waste treatment (not shown). Demineralized water fromwater supply 13 is then fed tocolumn 11 to elute the retained products and the eluted liquid is collected inreservoir 14. The thus obtained liquid product (liquid B) has a purity in hydroxytyrosol of at least 75%, and generally of at least 80%, the purity being determined as the % of the peak areas in a chromatogram by HPLC at 280 nm. The recovery of retained hydroxytyrosol from the resin is at least 85% and is generally at least 90%. -
FIG. 3 shows the relevant HPLC chromatogram of the obtained purified liquid product B. - In the second purification step, liquid product B is charged into
column 15, containing anon-ionic adsorption resin 16, as above detailed. The permeate is sent to waste treatment and the adsorbed hydroxytyrosol is recovered by elution with demineralized water fromsupply 13 and is collected inreservoir 17. - Liquid C, i.e. the liquid collected in
reservoir 17 has a purity in hydroxytyrosol of at least 90%, and generally of at least 95%, the purity being determined as the percent of the peak areas in a chromatogram by HPLC at 280 nm. The recovery of retained hydroxytyrosol from the resin is at least 90% and is generally at least 95% and substantially quantitative.FIG. 4 shows the relevant HPLC chromatogram of the obtained purified liquid product C. -
FIG. 1 also shows a source ofacetic acid 18 that is connected tocolumn 11 for acid activation ofresin 12 and a source ofNaOH 19 or other suitable base for regeneration of the same. Additionally, a source ofNaOH 19 for regeneration ofresin 16 is connected tocolumn 15 and a source ofsulphuric acid 21 for resin surface activation is also shown. - As for liquid A, also liquid B and liquid C can be concentrated in concentration means 10, e.g. by evaporation or TFF, preferably by reverse osmosis; concentration is preferably carried out on liquids B and C, preferably liquid C, to a hydroxytyrosol content that is easily up to 10%, and that can reach 20%, 35% and even 40% by weight of hydroxytyrosol in the concentrated liquid product (i.e. extract).
- In a further step of the invention process, the liquid products obtained by the previously discussed steps are dried in dryer means 20, e.g. freeze-dryer, vacuum rotoevaporator or preferably by spray-dryer, to produce a solid final product. The final product characteristics will be different according to the starting product (A, B or C) that is dried, the purity of the dry product being within the range of 45% to 99% (HPLC at 280 nm).
- This drying step is preferably carried out on liquid products B and C, after concentrating them as above disclosed. The drying step can advantageously make use of carriers suitable for the final use of the dry product; suitable carriers are e.g. maltodextrines, lactose, lecithins, caseinates etcetera.
- Suitable drying techniques are known in the art and comprise spray drying (usually with the use of carriers), freeze-drying and water evaporation under vacuum. The resulting products will have a hydroxytyrosol content of 0.5% to 10% and up to 20% (w/w) if a carrier is used, the hydroxytyrosol content can reach up to about 95% (w/w) if no carrier is used. It should be noticed that the invention process provides a purified liquid product (B and especially C) that is so pure that it can be evaporated to a dry powder even without carriers, this being not possible with known techniques.
- The extracts of the invention are suitable to prepare oral composition comprising olive polyphenols in an amount effective to provide in a daily serving at least 5 mg of hydroxytyrosol and its derivatives (e.g. oleuropein complex and tyrosol) wherein said olive polyphenols comprises a weight ratio of hydroxytyrosol to aldehydic form of oleuropein aglycone of between 5:1 and 850:1.
- The oral composition of the invention is comprising olive polyphenols in an amount effective to provide in a daily serving at least 5 mg of hydroxytyrosol and its derivatives (e.g. oleuropein complex and tyrosol) wherein said olive polyphenols comprises a weight ratio of hydroxytyrosol to oleuropein greater than 200:1.
- The invention will now be further disclosed with reference to the following non-limiting examples.
- 250 g of a sample of dry olive waste, orujillo, are mixed with 838 ml of demineralized water and 16.7 g of sulphuric acid (98%). The obtained mixture is kept in autoclave for 30 minutes at 121° C. After that, the aqueous phase is separated from the solid residue, by filtering on a filter. The solid phase, retained on the filter, is washed with 310 ml of demineralized water, and the water coming from this washing operation is collected with the aqueous phase previously recovered. The aqueous phase, approximately 860 ml, is then centrifuge refined to eliminate solid particles passed through the filter. After solid elimination, 835 ml of crude aqueous extract, containing 1.41 g of hydroxytyrosol, with a HPLC purity of 47.5%, are obtained.
- A sample of 835 ml of crude aqueous extract containing 1.41 g of hydroxytyrosol obtained according to Example 1, is loaded on a column containing a ion exchange resin of the anionic type, previously activated by means of acetate cycle. For example, Diaion WA10 may be used. The liquid phase recovered at the end of the column, does not contain any hydroxytyrosol, which is instead continuously eluted with demineralized water until at least 90% of the initially charged hydroxytyrosol is recovered. The eluted phase contains approximately 1.27 g of hydroxytyrosol with an HPLC purity of about 80.85%.
- A sample of 835 ml of crude aqueous extract containing 1.41 g of hydroxytyrosol obtained according to Example 1, is loaded on a column containing an ion exchange resin of the anionic type, previously activated by means of acetate cycle. For example, IRA-67 may be used. The liquid phase recovered at the end of the column, does not contain any hydroxytyrosol, which is instead continuously eluted with demineralized water until at least 90% of the initially charged hydroxytyrosol is recovered.
- The eluted phase coming from the first column, is charged on a column containing an adsorption resin. For example, resin XAD-1180 may be used. The liquid phase recovered at the end of the column, does not contain any hydroxytyrosol. Then, hydroxytyrosol is eluted from the resin with demineralized water until at least 90% of the initially charged hydroxytyrosol is recovered.
- The eluted phase contains approximately 1.14 g of hydroxytyrosol with an HPLC purity of about 95.72%.
- The aqueous phase obtained in Example 1 before the centrifugation step, approximately 860 ml, is concentrated by evaporation in order to reach a final volume of about 193 ml. The aqueous phase is then centrifuge refined to eliminate solid particles passed through the filter. After solid elimination, 160 ml of crude aqueous extract, containing 1.41 g of hydroxytyrosol, with a HPLC purity of 47.5%, are obtained.
- A sample of 80 l of crude aqueous extract containing 150 g of hydroxytyrosol obtained in a pilot plant according to Example 2, is concentrated using a reverse osmosis pilot plant, equipped with a 2.5 m2 polymeric membrane, in order to reduce the volume to 10 l of concentrate product. A 0.3 m2 membrane made of the same material is then used in order to obtain a hydroxytyrosol concentrate containing 10.8% of hydroxytyrosol with an HPLC purity of 80.53%.
- A sample of 546 l of crude aqueous extract containing 135 g of hydroxytyrosol obtained in a pilot plant according to Example 3, is concentrated using a reverse osmosis pilot plant, equipped with a 2.5 m2 polymeric membrane, in order to reduce the volume to 10 l of concentrate product. A 0.3 m2 membrane made of the same material is then used, in order to obtain a hydroxytyrosol concentrate containing 12.20% of hydroxytyrosol with an HPLC purity of 95.27%.
- A sample of 442 ml of crude aqueous extract containing 1.02 g of hydroxytyrosol obtained according to Example 1, is mixed with 100 g of maltodextrin, until maltodextrin was completely dissolved. For example, equivalent 10 dextrose potato maltodextrin may be used. A peristaltic pump is used to feed the spray-dryer, which is previously equilibrated with an inlet air temperature of 150° C. The feeding speed is adjusted in order to obtain an outlet air temperature which is less than 100° C. 95 g of a brown powder, with a moisture of 6.85% (Karl Fischer) and a hydroxytyrosol richness of 0.98%, are obtained.
- A sample of 290 ml of aqueous extract containing 0.38 g of hydroxytyrosol obtained according to Example 2 and subsequently concentrated by reverse osmosis is mixed with 50 g of maltodextrin until maltodextrin was completely dissolved. For example, equivalent 10 dextrose potato maltodextrin may be used. A peristaltic pump is used to feed the spray-dryer, which is previously equilibrated with an inlet air temperature of 150° C. The feeding speed is adjusted in order to obtain an outlet air temperature which is less than 100° C. 48.25 g of a greyish powder, with a moisture of 6.72% (Karl Fischer) and a hydroxytyrosol richness of 0.71%, are obtained.
- A sample of 188 ml of purified aqueous extract containing 0.29 g of hydroxytyrosol obtained according to Example 3, and subsequently concentrated by reverse osmosis, is slowly stirred with 28.5 g of maltodextrin. For example, equivalent 10 dextrose potato maltodextrin may be used. A peristaltic pump is used to feed the spray-dryer, which is previously equilibrated with an inlet air temperature of 175° C. The feeding speed is adjusted in order to obtain an outlet air temperature which is less than 100° C. 27.1 g of a white powder, with a moisture of 5.45% (Karl Fischer) and a hydroxytyrosol richness of 0.97%, are obtained.
- A sample of 1750 l of aqueous extract containing 432 g of hydroxytyrosol obtained, according to Example 3, in a pilot plant is concentrated according to Example 6, to obtain a hydroxytyrosol concentrate containing 39.04% of hydroxytyrosol with an HPLC purity of 95.60%. The concentrated solution is used to feed the spray-dryer, which is previously equilibrated with an inlet air temperature of 150° C. The feeding speed is adjusted in order to obtain an outlet air temperature less than 100° C. 375.84 g of a light brown powder, with a moisture of 4.35% (Karl Fischer) and a hydroxytyrosol richness of 94.74%, are obtained.
- 25 Kg of a sample of olives fruits are mixed with 50 L of demineralized water. The obtained mixture is blended for a few minutes, and then 636 g of sulphuric acid (98%) were added. The obtained mixture is kept in autoclave for 30 minutes at 121° C. After that, the aqueous phase is separated from the solid olive residue, by filtering on a filter. The solid phase, retained on the filter, is washed with 12.5 L of demineralized water, and the water coming from this washing operation is collected with the aqueous phase previously recovered. The aqueous phase, approximately 63 L, is then filtered trough a Kieselguhr filter pre-coated with a
Celite™ 500 diatomaceous earth to eliminate the extracted oil. The oil-free aqueous phase, about 56 L, is then centrifuge refined to eliminate solid particles passed through the Kieselguhr filter After solid elimination, 52 L of crude aqueous extract, containing 141 g of hydroxytyrosol, with a HPLC purity of 50.5%, are obtained. - Then, crude aqueous extract, is loaded on a column containing an ion exchange resin of the anionic type, previously activated by means of acetate cycle. For example, IRA-67 may be used. The liquid phase recovered at the end of the column, does not contain any hydroxytyrosol, which is instead continuously eluted with demineralized water until at least 90% of the initially charged hydroxytyrosol is recovered.
- The eluted phase coming from the first column is charged on a column containing an adsorption resin. For example, resin XAD-1180 may be used. The liquid phase recovered at the end of the column, does not contain any hydroxytyrosol. Then, hydroxytyrosol is eluted from the resin with demineralized water until at least 90% of the initially charged hydroxytyrosol is recovered.
- The eluted phase contains approximately 114 g of hydroxytyrosol with an HPLC purity of about 96.7%.
- Then, a 461 L fraction of purified extract containing 114 g of hydroxytyrosol obtained in a pilot plant is concentrated using a reverse osmosis pilot plant, equipped with a 2.5 m2 polymeric membrane, in order to reduce the volume to 10 l of concentrate product. A 0.35 m2 membrane made of the same material is then used, in order to obtain a hydroxytyrosol concentrate containing 3.5% of hydroxytyrosol. Finally the RO concentrate is rotaevaporated at 78° C. under a vacuum pressure of 245 mbar to allow about 10 times concentration of the olive fruit extract in liquid form reaching a final concentration of 37.2% (w/w) with an HPLC purity of 93.3%.
- A sample of 260 ml of purified olive extract in liquid form containing 19.5 g of hydroxytyrosol obtained according to Example 11, is slowly stirred with 58 g of maltodextrin previously dissolved in 260 ml of demineralized water. For example, potato maltodextrin may be used. A peristaltic pump is used to feed the spray-dryer, which is previously equilibrated with an inlet air temperature of 150° C. The feeding speed is adjusted in order to obtain an outlet air temperature which is less than 100° C. 76 g of a white powder, with a moisture of 5.4% (Karl Fischer) and a hydroxytyrosol richness of 21.9% (w/w), are obtained.
- 475.5 g of a sample of three phases pomace with a humidity of 60.55%, are mixed with 800 ml of demineralized water and 26.36 g of sulphuric acid (98%). The obtained mixture is kept in autoclave for 30 minutes at 121° C. After that, the aqueous phase is separated from the solid residue, by filtering on a 600 micron polypropylene filter. The filtered aqueous phase, approximately 795 ml, is concentrated by evaporation in order to reach a final volume of about 343.8 ml. The aqueous phase is then centrifuge refined to eliminate solid particles passed through the filter. After solids elimination, 275 ml of crude aqueous extract, containing 0.97 g of hydroxytyrosol, with a HPLC purity of 54%, are obtained.
- A sample of 275 ml of crude aqueous extract containing 0.97 g of hydroxytyrosol obtained according to Example 13, is loaded on a column containing an ion exchange resin of the anionic kind, previously activated by means of acetate cycle. For example, Diaion WA10 resin may be used. The liquid phase recovered at the end of the column, does not contain any hydroxytyrosol, which is instead continuously eluted with demineralized water until at least 90% of the initially charged hydroxytyrosol is recovered.
- The eluted phase coming from the first column is loaded on a column containing an adsorption resin. For example, resin Diaion HP20 may be used. The liquid phase recovered at the end of the column, does not contain any hydroxytyrosol. Then, hydroxytyrosol is eluted from the resin with demineralized water until at least 90% of the initially charged hydroxytyrosol is recovered.
- The eluted phase contains approximately 0.80 g of hydroxytyrosol with an HPLC purity which is higher than 95%.
-
- As previously mentioned, the process of the invention provides for preparing an extract containing hydroxytyrosol starting from olives and/or pomaces without making use of organic polar solvents. The products obtained according to this process, both the final products and the intermediate products, are therefore free from organic polar solvents. The products are also substantially free from sugars and salts. This is possible by the combined use of the claimed hydrolysis conditions and purification procedure.
- The final product, because of its high purity and high hydroxytyrosol content, in particular a solid hydroxytyrosol extract free from carriers and organic solvents is highly suitable for use in the food industry, and in cosmetic and pharmaceutical industries.
-
FIG. 5 is a chromatographic profile showing the separation of hydroxytyrosol and tyrosol peaks in adsorption column eluted with water. Also 2 marks are signaling the bed volumes at whichsample spot 2 a andsample spot 2 b were taken.FIG. 6 a is a HPLC chromatogram of thesample spot 2 a (punctual sample at 2 BV) taken during collection of eluate fraction showing a complete separation of hydroxytyrosol and tyrosol in adsorption column eluted with water.FIG. 6 b is a HPLC chromatogram of thesample spot 2 b taken (punctual sample at 11.8 BV), showing contamination of hydroxytyrosol with tyrosol that is eluted later than hydroxytyrosol in adsorption column eluted with water. - Collection of eluate fraction is preferably completed after 9.8 BV avoiding ratios of hydroxyrtyrosol/Tyrosol lower than 55.
- 2367 Kg of orujillo are loaded with 10250 L of demineralized water into a stirred glass lined reactor at atmospheric pressure. The obtained mixture is stirred for a few minutes, and then sulphuric acid (98%) was added to adjust to pH 1.50. The obtained mixture is kept stirred into a glass lined
reactor 4 hours at 70° C. After that, NaOH (50%) was added to the reactor to adjust to pH 2.5±0.5, and then, the aqueous phase is separated from the solid olive residue, by using a centrifugal decanter. The solid phase was sent to waste handling. The aqueous phase, approximately 7900 L, is then centrifuge refined to eliminate the small solid particles passed through the centrifugal decanter step. After solid elimination, 7500 L of crude aqueous extract, containing 9.55 Kg of hydroxytyrosol, with a HPLC purity of 52.7%, were obtained; the weight ratios hydroxytyrosol/hydroxymethylfurfural (w/w), hydroxytyrosol/oleuropein and hydroxytyrosol/aldehydic form of oleuropein aglycone were found to be the values of 82, 289 and 8 respectively. - A sample of crude aqueous extract was dried till moisture content lower than 10%, and then the content in PAHs was analyzed. The following data are the results:
-
benzo[a]pyrene<2 microg/Kg (quantification limit: 2 microg/Kg) -
benzo(b)fluorantene<10 microg/Kg (quantification limit: 10 microg/Kg) -
benzo(k)fluorantene<10 microg/Kg (quantification limit: 10 microg/Kg) -
Benzo[g,h,i]perylene<10 microg/Kg (quantification limit: 10 microg/Kg) -
indene(1,2,3-cd)pyrene<10 microg/Kg (quantification limit: 10 microg/Kg) - Then, the crude aqueous extract is loaded on a column containing an ion exchange resin of the anionic type, previously activated by means of citrate cycle. For example, IRA-67 may be used. The liquid phase recovered at the end of the column, does not contain any hydroxytyrosol, which is instead continuously eluted with demineralized water until at least 90% of the initially charged hydroxytyrosol is recovered.
- The eluted phase coming from the first column is concentrated by reverse osmosis till a final volume equivalent to 1.8 bed volumes of the adsorption resin contained at the second column. The reverse osmosis concentrate is charged at the second column containing an adsorption resin. For example, 1000 L resin XAD-1180 may be used, then the loaded reverse osmosis concentrate is 1800 L (1.8 bed volumes). The liquid phase recovered at the end of the column after complete the loading phase of reverse osmosis concentrate (column permeate fraction), does not contain any hydroxytyrosol. After that, resin is washed with 1.33 bed volumes of water. Then the water elution phase starts, and the column eluate fraction is collected into the purified product tank. Hydroxytyrosol is eluted from the resin with 8.45 bed volumes of demineralized water (same quality that the one used for the washing step) until the HPLC analysis of a spot sample of the eluate take at outlet of the column presents a ratio hydroxytyrosol/tyrosol (w/w) lower than 15/1. The chromatographic profile showing the separation of hydroxytyrosol and tyrosol peaks is presented in
FIG. 5 . Presence of oleuropein and aldehydic form of oleuropein aglycone is checked by HPLC but these compounds are not detectable at any moment during the elution step, being the detection limits for bothcompounds 500 ppm. - The eluted phase contains approximately 7400 g of hydroxytyrosol (at least 90% of the initially loaded hydroxytyrosol) with an HPLC purity of about 95.7% and a ratio hydroxytyrosol/tyrosol (w/w) of 113/1.
- Then, the eluted fraction of purified extract containing 7400 g of hydroxytyrosol is concentrated by reverse osmosis, in order to reduce the volume to 230 L of concentrate product. Finally the RO concentrate is rotaevaporated at 78° C. under a vacuum pressure of 245 mbar to allow about 14 times concentration of the olive fruit extract in liquid form reaching a final hydroxytyrosol concentration of 41.5% (w/w) with an HPLC purity of 94.8% and a ratio hydroxytyrosol/tyrosol (w/w) of 110/1 (see
FIG. 5 ) and a ratio hydroxytyrosol/hydroxymethylfurfural (w/w), of 9050 was obtained. Presence of oleuropein and aldehydic form of oleuropein aglycone is checked by HPLC at olive fruit extract in liquid form (final product) but these compounds are not detectable, being the detection limits for bothcompounds 500 ppm (seeFIG. 6 a,FIG. 6 b andFIG. 7 for identification of hydroxytyrosol, tyrosol, oleuropein and aldehydic form of oleuropein aglycone, comparison of peak profile and retention time of every compound). As the hydroxytyrosol content (w/w) was 41.5% and the detection limits for oleuropein and aldehydic form of oleuropein aglycone, 500 ppm a theoretical weight ratio hydroxytyrosol/oleuropein and hydroxytyrosol/aldehydic form of oleuropein aglycone could be calculated, being the theoretical value higher than 830. - The oleuropein of
FIG. 7 is initially present in a sample of olive leaf extract purchased from Naturex; it was hydrolysed with beta-glucosidase from almond (purchased at Sigma) during 1 h at 25° C. at pH 5.0 in 100 mM sodium phosphate buffer. It is shown for comparative reasons withFIGS. 6 a and 6 b, especially to identify the retention times of oleuropein and aldehydic form of oleuropein aglycone formed during the reaction - The ion species detected in purified olive extract in liquid form having a hydroxytyrosol concentration of 41.5% (w/w) with an HPLC purity of 94.8% and a ratio hydroxytyrosol/tyrosol (w/w) of 110/1 obtained according to Example 15 on the HPLC-DAD-MS systems are shown in
FIG. 9 . -
FIG. 10 shows a chromatogram DAD (280 nm); BPC (Base Peak Chromatogram) in negative (−) and positive (+) ionization mode, for purified olive extract in liquid form having a hydroxytyrosol concentration of 41.5% (w/w) with an HPLC purity of 94.8% and a ratio hydroxytyrosol/tyrosol (w/w) of 110/1 obtained according to Example 15 dissolved in MeOH 0.1% HCOOH 100 mg/ml. - The process of production of olive extracts from orujillo described at example 15, was carried out for 17 different production lots. The extension of the washing step was maintained fix (1.3 to 1.5 bed volumes), but the extension of the elution step was tested in the
range 7 to 10 bed volumes, as shorter the bed volumes used for elution as higher the ratio hydroxytyrosol/tyrosol (w/w) obtaining values for such ratio from 55/1 to 618/1 (FIG. 8 a). For all the analyzed lots the recovery of initially charged hydroxytyrosol at the eluted fraction is at least 80%. Presence of oleuropein and aldehydic form of oleuropein aglycone is checked by HPLC for every batch but these compounds are not detectable at any moment during the elution step nor in the final product. - The ratio hydroxytyrosol/hydroxymethylfurfural (w/w) was calculated for the crude aqueous extract after centrifugation, but before column purification the values were in the range 45:1 to 136:1 (see
FIG. 8 b). - A sample of 16 Kg of purified olive extract in liquid form containing 6640 g of hydroxytyrosol obtained according to Example 15, is slowly stirred with 19 Kg of maltodextrin previously dissolved in 220 L of demineralized water. For example, potato maltodextrin may be used. The solution is pumped to feed the spray-dryer, which is previously equilibrated with an inlet air temperature of 150° C. The feeding speed is adjusted in order to obtain an outlet air temperature which is less than 78° C. A production lot of 26.2 Kg of a white powder, with a moisture of 3.4% (Karl Fischer) and a hydroxytyrosol content of 22.8% (w/w), and a ratio hydroxytyrosol/tyrosol (w/w) of 115/1 and a ratio hydroxytyrosol/hydroxymethylfurfural (w/w), of 9136 were obtained.
- A sample of 500 g of purified olive extract in liquid form having a hydroxytyrosol concentration of 41.5% (w/w) with an HPLC purity of 94.8% and a ratio hydroxytyrosol/tyrosol (w/w) of 110/1 obtained according to Example 15 was used as test item with the aim of identifying described phenolic compounds (hydroxytyrosol, tyrosol, etc.) and the presence of impurities. HPLC-DAD-MS systems with two types of mass analyzers: TOF (Time of Flight) and IT (Ion Trap). The former provides the exact mass of a given molecule and with the aid of the external laboratory of analysis database a possible identity can be established. In addition, the identity of the target compound could be confirmed by MSn experiments provided by the Ion Trap. A specific search of oleuropein and aldehydic form of oleuropein aglycone has been carried out.
- The chromatographic separation is performed on a rapid
resolution C18 column 50×3.0 mm, 1.8 μm under gradient conditions. The mobile phase consists of a mixture of methanol and water, both containing 0.1% of formic acid, with the aim of promoting the ionization of the compounds in samples. - The signals are registered in a diode array detector (at 280 nm) and in a TOF mass spectrometer detector with an electrospray ion source (ESI).
- In addition, an ion trap mass analyzer has been used with the aim of elucidating and confirming the molecules structures, which has been previously identified in the RRLC-TOF system. For this purpose, a
C18 column 150×2.1 mm, 3.5 μm is used under gradient conditions, because d the system cannot work at pressures above 400 bars. The rest of chromatographic conditions are the same as those described in the previous section. - The identified chromatographic peaks are compiled in
FIG. 9 and the chromatographic profile and composition is presented inFIG. 10 . There are only selected the ones that have a certain absorbance at 280 nm, because this is the specific wavelength for phenolic compounds. -
FIG. 9 shows the results obtained with IT and TOF mass analyzers. In both cases, the ionization has been carried out in negative and positive polarity. Therefore, the ions obtained in each ionization mode are shown in the table attached to the ionic species detected. - Concerning to the phenolic compounds, the presence of hydroxytyrosol (peak 2) and tyrosol (peak 4) has been confirmed. The tyrosol molecule is not ionized in the operating conditions, and it has been identified by comparison of the retention time with a commercial standard. Oleuropein and aldehydic form of oleuropein aglycone, which are other phenolic compounds of interest, have not been detected in the analyzed olive extract.
- A sample of 518 g of purified olive extract in form of white powder, with a moisture of 3.4% (Karl Fischer) and a hydroxytyrosol content of 22.8% (w/w), and a ratio hydroxytyrosol/tyrosol (w/w) of 115/1 obtained according to Example 16, was filled into a biconic mixer and after that 1978 g of potato maltodextrin, 52 g of magnesium esterate and 52 g of tri-calcium phosphate, total batch size 2600 g. After 15 minutes of mixing the powder has an improved flowability in comparison with the initial olive extract, allowing a very good filling of hard gelatine capsules of
size 00, with a very accurate net weight of 0.294±0.012 g (seeFIG. 11 ). - The capsules were automatically cleaned externally and filled into a blistering machine that produces the blisters with 30 capsules. Finally blisters were manually introduced into the final packing.
- The objective of the study was to analyze the protection of blood lipids from oxidative stress due to the intake of the oral compositions of olive oil added with a hydroxytyrosol-rich olive extract in a human intervention study by measuring the serum levels of oxidized LDL.
- The selection of participants in the pilot study has followed a series of criteria listed below:
- 1. All participants must give their written informed consent after receiving oral and written information about the study
- 2. Aged between 18 and 65
- 3. Body mass index (BMI) between 18.5 and 30 kg/m2
- 4. Healthy men (without known diseases, including hypertension, hypercholesterolemia, diabetes and psoriasis)
- 5. Not having used dietary supplements or having donated blood two months before the study and during its development
- 1. Cardiovascular disease at the time of the study or before that
- 2. Diabetes mellitus or other serious chronic disease, including allergies and severe psoriasis at the time of the study or before that
- 3. Hypertension at the time of the study or before that
- 4. Knowledge or belief of alcohol, drugs or medication abuse
- All participants have the right to withdraw at any time without explanation. In addition, participants may be excluded from the intervention if failure to follow the study guidelines occurs.
- There are no side effects expected in this study.
- The number of participants in this study was that of 20, divided in two groups of 10 participants who consumed:
-
- Group 1: 25 ml extra virgin olive oil (without addition of olive extract, used as control) daily at a single dose.
- Group 2: 25 ml fortified extra virgin olive oil (with addition of an olive extract prepared according ex. 15, providing a dose of 5 mg of hydroxytyrosol and its derivatives (e.g. oleuropein complex and tyrosol) daily at a single dose.
- The duration of the study was that of 4 weeks. Blood samples were taken in fasting at
days - With the blood samples the measurement of oxidized LDL was performed:
- The analysis of results showed a 35% decrease at the plasmatic level of oxidized LDL in the
group 2 participants. Such difference at the level of oxidized LDL was determined as statistically significantive when compared with the control group, p<0.01 (Tukey's Test). The results of the intervention study are shown in theFIG. 12 . - While preferred embodiments of the invention have been shown and described herein, it will be understood that such embodiments are provided by way of example only. Numerous variations, changes and substitutions will occur to those skilled in the art without departing from the spirit of the invention. Accordingly, it is intended that the appended claims cover all such variations as fall within the spirit and scope of the invention.
Claims (16)
1.-15. (canceled)
16. A dietary supplement comprising an olive extract containing a weight ratio of hydroxytyrosol to oleuropein greater than 200:1.
17. A dietary supplement comprising an olive extract containing a weight ratio of hydroxytyrosol to aldehydic form of oleuropein aglycone of between 5:1 and 850:1.
18. A dietary supplement comprising an olive extract containing a weight ratio of hydroxytyrosol to tyrosol of between 55:1 and 618:1.
19. An oral composition comprising olive polyphenols in an amount effective to provide in a daily serving at least 5 mg of hydroxytyrosol and its derivatives wherein said olive polyphenols comprise a weight ratio of hydroxytyrosol to tyrosol of between 55:1 and 618:1.
20. A method of protecting blood lipids in a subject from oxidative stress, wherein the method comprises administering to the subject the oral composition according to claim 19 .
21. An oral composition comprising olive polyphenols in an amount effective to provide in a daily serving at least 5 mg of hydroxytyrosol and its derivatives wherein said olive polyphenols comprise a weight ratio of hydroxytyrosol to aldehydic form of oleuropein aglycone of between 5:1 and 850:1.
22. A method of protecting blood lipids in a subject from oxidative stress, wherein the method comprises administering to the subject the oral composition according to claim 21 .
23. An oral composition comprising olive polyphenols in an amount effective to provide in a daily serving at least 5 mg of hydroxytyrosol and its derivatives wherein said olive polyphenols comprise a weight ratio of hydroxytyrosol to oleuropein greater than 200:1.
24. A method of protecting blood lipids in a subject from oxidative stress, wherein the method comprises administering to the subject the oral composition according to claim 23 .
25. The dietary supplement of claim 16 , additionally comprising a carrier.
26. The dietary supplement of claim 17 , additionally comprising a carrier.
27. The dietary supplement of claim 18 , additionally comprising a carrier.
28. The oral composition of claim 19 , additionally comprising a carrier.
29. The oral composition of claim 21 , additionally comprising a carrier.
30. The oral composition of claim 23 , additionally comprising a carrier.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/600,174 US20150196498A1 (en) | 2007-01-26 | 2015-01-20 | Hydroxytrosol containing extract obtained from olives and solids containing residues of olive oil extraction |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES07001791.8 | 2007-01-26 | ||
EP07001791A EP1953133A1 (en) | 2007-01-26 | 2007-01-26 | Process and apparatus for the production of hydroxytyrosol from olive oil extraction residues |
ES07014390.4 | 2007-07-23 | ||
EP07014390 | 2007-07-23 | ||
PCT/IB2008/000173 WO2008090460A1 (en) | 2007-01-26 | 2008-01-25 | Process and apparatus for the production of hydroxytyrosol containing extract from olives and solids containing residues of olive oil extraction |
US52460309A | 2009-12-15 | 2009-12-15 | |
US13/543,086 US8968811B2 (en) | 2007-01-26 | 2012-07-06 | Hydroxytrosol containing extract obtained from olives and solids containing residues of olive oil extraction |
US14/600,174 US20150196498A1 (en) | 2007-01-26 | 2015-01-20 | Hydroxytrosol containing extract obtained from olives and solids containing residues of olive oil extraction |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/543,086 Division US8968811B2 (en) | 2007-01-26 | 2012-07-06 | Hydroxytrosol containing extract obtained from olives and solids containing residues of olive oil extraction |
Publications (1)
Publication Number | Publication Date |
---|---|
US20150196498A1 true US20150196498A1 (en) | 2015-07-16 |
Family
ID=48744337
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/543,086 Active 2028-03-21 US8968811B2 (en) | 2007-01-26 | 2012-07-06 | Hydroxytrosol containing extract obtained from olives and solids containing residues of olive oil extraction |
US14/600,174 Abandoned US20150196498A1 (en) | 2007-01-26 | 2015-01-20 | Hydroxytrosol containing extract obtained from olives and solids containing residues of olive oil extraction |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/543,086 Active 2028-03-21 US8968811B2 (en) | 2007-01-26 | 2012-07-06 | Hydroxytrosol containing extract obtained from olives and solids containing residues of olive oil extraction |
Country Status (1)
Country | Link |
---|---|
US (2) | US8968811B2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8968811B2 (en) * | 2007-01-26 | 2015-03-03 | Probelte Pharma, S.A. | Hydroxytrosol containing extract obtained from olives and solids containing residues of olive oil extraction |
US10532990B2 (en) * | 2014-12-12 | 2020-01-14 | Virdia, Inc. | Methods for converting cellulose to furanic products |
WO2019116343A1 (en) * | 2017-12-14 | 2019-06-20 | Universidade Do Porto | Foodstuff composition comprising a derivate of olive pomace |
CN111436574B (en) * | 2020-04-02 | 2023-07-14 | 合肥工业大学 | Baking method for controlling content of heterocyclic amine and polycyclic aromatic hydrocarbon in beef steak |
GR1010150B (en) * | 2020-11-26 | 2022-01-12 | Stymon Natural Products Ικε, | Method for the production of a natural product derived from olive mill waste water - natural product rich in aromatic, tasty and phenolic substances |
PT118300A (en) * | 2022-10-31 | 2024-04-30 | Silva Pinto Agro Lda | OIL PRODUCTION PROCESS WITH HIGH CONTENT OF ANTIOXIDANTS AND AN ANTIOXIDANT CONCENTRATE |
CN115998653A (en) * | 2022-12-22 | 2023-04-25 | 嘉文丽(福建)化妆品有限公司 | Preparation of olive leaf extract rich in hydroxytyrosol and application of olive leaf extract in cosmetics |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8968811B2 (en) * | 2007-01-26 | 2015-03-03 | Probelte Pharma, S.A. | Hydroxytrosol containing extract obtained from olives and solids containing residues of olive oil extraction |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000038541A1 (en) | 1998-12-23 | 2000-07-06 | Unilever N.V. | Fortification of food products with olive fruit ingredients |
US6358542B2 (en) | 1999-12-20 | 2002-03-19 | Usana, Inc. | Antioxidant compositions extracted from olives and olive by-products |
US7713569B2 (en) | 2000-09-01 | 2010-05-11 | Creagri, Inc. | Hydroxytyrosol-rich composition from olive vegetation water and method of use thereof |
WO2002064537A1 (en) | 2001-02-15 | 2002-08-22 | Consejo Superior De Investigaciones Cientificas | Method for obtaining purified hydroxytyrosol from products and by-products derived from the olive tree |
ES2199069B1 (en) | 2002-07-17 | 2005-02-01 | Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas, (C.I.E.M.A.T) | PROCEDURE FOR THE EXTRACTION OF PHENOLIC COMPOUNDS FROM A RESIDUAL VEGETABLE MATERIAL THROUGH A HYDROTHERMIC TREATMENT. |
EP1582512A1 (en) | 2004-03-31 | 2005-10-05 | Cognis IP Management GmbH | Process for obtaining hydroxytyrosol from olive leaves extracts |
ITMI20041627A1 (en) | 2004-08-06 | 2004-11-06 | Lachifarma S R L Lab Chimi Co | PROCESS FOR THE RECOVERY OF THYROSOL HYDROXYTYROSOL AND OTHER PHENOLIC COMPONENTS FROM VEGETATION WATERS AND METHOD OF CATALYTIC OXIDATION OF THYROXIS TO HYDROXYSIROSOL |
-
2012
- 2012-07-06 US US13/543,086 patent/US8968811B2/en active Active
-
2015
- 2015-01-20 US US14/600,174 patent/US20150196498A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8968811B2 (en) * | 2007-01-26 | 2015-03-03 | Probelte Pharma, S.A. | Hydroxytrosol containing extract obtained from olives and solids containing residues of olive oil extraction |
Also Published As
Publication number | Publication date |
---|---|
US8968811B2 (en) | 2015-03-03 |
US20130178537A1 (en) | 2013-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20150196498A1 (en) | Hydroxytrosol containing extract obtained from olives and solids containing residues of olive oil extraction | |
JPH0144234B2 (en) | ||
KR101062670B1 (en) | Composition for the prevention or treatment of obesity-related diseases mediated by the activation of AMPK containing 2,5-bis-aryl-3,4-dimethyltetrahydrofuran lignan as an active ingredient | |
US6264853B1 (en) | Complex containing lignan, phenolic and aliphatic substances from flax and process for preparing | |
JP2011514347A (en) | Extracts from oil palm leaves containing phenolic acid | |
JP7333815B2 (en) | COMPOSITION FOR IMPROVING LIVER FUNCTION | |
TWI610680B (en) | Olive extract containing Des Rhamnosyl Acteoside | |
JP2006321772A (en) | Anti-obesity agent | |
JP6042800B2 (en) | Tomatoside A extraction method | |
Suhendi | Potential Activity of Rambutan (Nepheliumlappaceum L.) Fruit Peel Extract as Antidiabetic and Antihypercholesterolemia | |
JP2001302533A (en) | Liver function enhancer | |
KR101082938B1 (en) | Vitamin agent composition comprising enrichmented water-soluble vitamins and method for preparing thereof | |
JP6460402B2 (en) | Pharmaceutical composition or food composition for promoting cholesterol excretion | |
JP4295301B2 (en) | Meat odor improving agent, meat odor improving method using the same, and meat product | |
JP4041843B2 (en) | Pharmaceutical composition containing quercetin 3-o- (6-o-malonyl) glucoside as an active ingredient and food containing quercetin malonyl glucoside | |
JP5398101B2 (en) | Absorption enhancer of bark extract component containing sphingolipid as active ingredient | |
KR20060120096A (en) | Plant seed extract composition and process for producing the same | |
CN108349877B (en) | Novel citric acid derivatives | |
RU2314118C1 (en) | Method for preparing extracts possessing antioxidant activity from cultivated grape compound fruit racemes | |
EP0078028B1 (en) | Antihypertensive agents and process for producing the same | |
JP2019163234A (en) | Xanthine oxidase inhibitor and method for producing the same | |
JP2011074028A (en) | Lipase inhibitor and food and drink containing the same | |
JPWO2005070443A1 (en) | Bark extract | |
JP2005320262A (en) | Agent for suppressing elevation of blood sugar level containing acerola seed extract, age formation inhibitor and food containing them | |
US8178135B2 (en) | Aqueous solution of conophylline and/or conophyllidine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |